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ABSTRACT

Stuckey, Crystal Elaine. M.S., Department of Neuroscience, Cell Biology, and
Physiology, Wright State University, 2008. Oxidative Stress and Cell Death in
Osmotically Swollen Glial Cells.

Regulation of normal volume is an important aspect of cell homeostasis. Possible
mechanisms which signal volume regulation are increasing the rate of reactive oxygen
species (ROS) production and release of ATP for interaction with purinergic receptors.
We examined whether an increase in ROS production during cell swelling also led to cell
injury of C6 glioma cells. Cells were loaded with 5,6-carboxy-2,7-dihydrofluorscein
diacetate (DCFDA) to fluoroscopically measure the rate of cellular ROS production and
were perfused with phosphate-buffered saline solutions (PBS) containing 100 µM
carbenoxolone to inhibit dye efflux. Cell death was determined cytometrically and by
measuring the release of lactate dehydrogenase (LDH) into the culture medium 24 hr
after exposing cells for 60 min to isoosmotic or hypoosmotic PBS. Immediately after
changing the perfusion solution from isoosmotic to hypoosmotic PBS, the production of
ROS increased by 60.2% + 19.6, but returned to baseline after 5 min. Increased efflux of
ATP was not observed in hypoosmotic conditions. ROS production was not directly
activated by endogenously applied extracellular ATP, but ATP increased ROS production
in swollen cells. Cells swollen by hypoosmotic solutions had a slight increase in the
probability of necrotic cell death. Our data suggest that increased ROS produced by cells
swollen during hypoosmotic stress does not lead to significant cell injury in cultured C6
cells.
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I. Introduction and Purpose
Introduction
The redox state of a cell is highly regulated and is determined in part by the ratio
of free radicals to antioxidants present within the cell. A predominate class of free
radicals is reactive oxygen species (ROS). ROS are highly reactive molecules and are
used in many ways by a cell including the regulation of cellular processes [59, 72]. If the
ROS levels get out of physiological ranges they can cause cell injury and death. ROS can
be produced by several different intracellular sources such as NADPH oxidase complex,
mitochondrial electron transport chain, xanthine oxidase, and nitric oxide synthase [2, 21,
68, 104]. Many cell types have been known to increase their production of ROS when
they are under mechanical or osmotic stress. Regulation of volume is especially
important when the cells are exposed to anisoosmotic conditions. Two potential signals
for volume regulation when a cell is exposed to anisoosmotic conditions are ROS and
ATP. Volume regulation can be accomplished with activation of ROS, ATP, or a
combination of both of these compounds. Activation of volume regulatory processes
allows the cell to efflux ions and organic osmolytes which draws water out of the cell.
This study was designed to determine if there was an increase in ROS production during
hypoosmotic swelling which led to an increase in cytotoxicity, and to determine the role
of ATP in the regulation of ROS production.
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Cell Volume Regulation
Cell volume regulation is an important aspect of the life of a cell. Cells must be
able to regulate their volume in isoosmotic conditions as well as anisoosmotic conditions.
The mammalian cell is only protected by a selectively permeable phospholipid membrane
that allows water to move freely across the membrane. When the osmotic environment
changes in or around the cell, water moves causing the cell to swell or shrink. If too
much water moves into the cell it can cause rupturing of the membrane. On the other
hand, if too much water leaves the cell, the internal environment will become too
concentrated with ions and the cell will not be able to carry out its normal functions. The
ways in which a cell is able to control its volume are by changing the intracellular
osmolyte content through movement of ions and organic osmolytes across the plasma
membrane, anabolism, and catabolism. Among other functions, plasma membrane
channels allow the movement of small or charged molecules to move through the plasma
membrane. Thus cells use the phospholipid bilayer and proteins embedded within the
bilayer to control the environment of the interior of the cell and maintain a dynamic, but
steady volume [153].
In steady state conditions, there is a constant risk to cell volume equilibrium due
to the asymmetrical distribution of ions and osmotic macromolecules across the cell
membrane. The Gibbs-Donnan equilibrium principle states that the sum of the
monovalent cations times sum of the monovalent anions on one side of the membrane is
equal to the products of the activities of the sum of these ions on the other side of the
membrane. Thus, for a simple solution containing only intracellular (i) and extracellular
(o) potassium and chloride:
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[K+]i x [Cl]i = [K+]o x Cl]o

[1]

Mammalian cells use a system similar to the Gibbs-Donnan system known as the double
Donnan principle to control water movement across the membrane. For this system, an
extracellular solute, sodium (Na+), can balance the osmotic pressure of the intracellular
macromolecules. In order for this to work, the cell has to be effectively impermeable to
this solute. If the solute has some permeability through the cell membrane, the cell must
transport this solute out of the cell as fast as it enters the cell. This is accomplished with
the Na+/K+ pump. Sodium is pumped out of the cell, against its gradient, and potassium
(K+) into the cell. Outward transport of sodium maintains a low intracellular
concentration and high extracellular concentration of Na+. This process moves Na+
against its electrochemical gradient and is therefore an energy dependent process [82,
102, 119].
If the double Donnan equilibrium is disrupted by anisoosmotic conditions, water
will move in or out of the cell causing the cell to swell or shrink, respectively, in order to
regain osmotic balance across the plasma membrane. Anisoosmotic changes alter the cell
membrane causing membrane blebbing and rapid changes of the actin cytoskeleton [119].
Once most mammalian cells are exposed to a change in osmolarity they activate
processes to return the cell to normal size. These processes are known as regulatory
volume increase (RVI) and regulatory volume decrease (RVD). Both processes may be
activated by a cell’s ability to monitor [Cl]i (intracellular chloride) and macromolecule
concentrations within the cell [119]. Other processes are important in recognizing
changes and maintaining cell volume such as stretch activated channels and changes in
the cytoskeleton. The altered ionic concentrations caused by cell shrinking or swelling
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can cause a change in catalytic rates, ligand binding abilities, structural conformation,
and protein assembly [151, 153]. These are some of the stimuli that cells use to monitor
changes in cell volume, but the mechanism of activation of RVI and RVD are not entirely
clear. If a cell is unable to regulate its volume by RVI or RVD the cell will die by
necrosis or apoptosis [119, 162].

Regulatory Volume Increase
When a cell is introduced to a hyperosmotic environment, the cell will shrink as
water moves out of the cell to maintain osmotic balance across the plasma membrane.
Once the cell shrinks in hyperosmotic conditions a process known as regulatory volume
increase (RVI) may be initiated which increases the size of the cell toward its initial cell
volume despite continuous osmotic stress. RVI occurs in two steps; the initial step is fast
occurring within minutes and is accomplished with inorganic osmolytes and electrolytes
[29]. Within minutes of a hyperosmotic change, there is an influx of Na+, K+, Cl, H+,
and HCO3 ions. Then water follows, increasing the cell size to a normal volume [29, 83,
121, 153, 165]. The cell cannot function properly at this altered ionic concentration;
therefore, a second process is activated using organic osmolytes [29]. The movement of
organic osmolytes is a slower process that takes hours to days because organic osmolytes
are either proteins that have to be synthesized within the cell or small molecules that are
brought into the cell via energy-dependent transport [153, 165]. The three primary
categories of organic osmolytes used for hyperosomtic volume regulation are polyols
such as sorbitol and myoinositol, amino acids such as taurine, and methylamines such as
betaine and glyerophosphocholine [29, 153, 165]. These organic osmolytes accumulate

4

within the cell so that the cell is able to remain at homeostatic size and recover normal
ionic concentrations.
Two known mechanisms that regulate volume after cell shrinkage are the Na+/H+
exchanger combined with Cl/HCO3 exchanger and Na+-K+-2Cl co-transporter [121,
153, 165]. Ehrlich ascites cells and vascular endonthelial cells use the Na+/H+ exchanger
also acting with the Cl/HCO3 exchanger [77, 88]. The Na+/H+ exchanger is present in
C6 cells, but is primarily responsible for maintaining pH and can be activated by an
acidic intracellular pH [76, 115, 149]. The Na+/H+ exchanger also is activated during
RVI. During RVI the kinetics of the exchanger are slightly modified, but according to
Mountian et al., ion exchange due to the Na+/H+ exchanger is not large enough to effect
RVI [76, 115]. The main effector of RVI in C6 cells is the Na+-K+-2Cl co-transporter
which, when activated, causes an increase in the levels of NaCl and KCl within the cell
[115, 165]. In C6 cells, increase in intracellular Na+ enhances activity of Na+-K+ATPase which exchanges Na+ for K+. This causes Na+ to move out of the cell in an
overall cyclic manner when working along with the co-transporter [40, 47, 115].
Movement of ions leads to an increase in intracellular KCl and movement of water into
the cell which enables the cell to regain original cell volume [40, 83, 115]. Inorganic
osmolytes and free organic osmolytes allow the cell to regulate volume quickly, but long
term RVI is accomplished using organic osmolytes that are made by the cell during the
osmotic stress.
Organic osmolytes also play an important role in RVI. They allow the cell to
control both cell volume and intracellular ionic concentrations when exposed to
prolonged hyperosmotic conditions. The advantage of organic osmolytes is that they are
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nonperturbing solutes that can accumulate to high concentrations within the cell without
disrupting cell function [151]. Cells can also undergo large shifts of organic osmolytes
without effects on cell structure or function [153]. Myo-insitol is one of many organic
osmolytes, such as sorbitol, taurine, betaine, and glyerophosphocholine, that cells use to
maintain their volume during hyperosmotic stress [29, 40, 124, 165]. Minami et al. found
that changes in organic osmolytes did not alter cellular structure or function. They did
this by injecting rats intraperitoneally with hypertonic solutions, removing the rat brains
and measuring the accumulation of the Na+/myo-insitol co-transporter [112]. Expression
of the Na+/myo-insitol co-transporter peaked shortly after exposure and then expression
of the co-transporter leveled off to a normal level. The importance of the Na+/myoinsitol co-transporter is evident in that most glial cells and neurons express the cotransporter [112].

Regulatory Volume Decrease
When mammalian cells are exposed to hypoosmotic solutions they initially swell
and then regulate volume. The mechanism which triggers volume regulation is still
unclear. Activation of volume regulation could result directly from changes in
intracellular ionic strengths, tension on the cell membrane due to cell volume changes, or
a combination of both [156]. Volume regulation in the cell is generally dependent on
efflux of K+, Cl, and organic osmolytes. Charged or small particles exit the cell via
protein channels and water follows the electrolytes resulting in decreased volume of the
cell, a process known as regulatory volume decrease (RVD). Activation of the volume
regulatory channels is a rapid process because the channels are permanently located on
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the membrane or stored in submembrane cytoplasmic vesicles [153]. For RVD to be
effective, ionic fluxes must be electroneutral [23]. As the cell releases K+ into the
extracellular space, it also fluxes an anion, Clֿ, at the same rate either by two separate
transporters or a single co-transporter. One pathway is the electroneutral KCl cotransporter (KCC) which is used by cells that have a slow onset of RVD, a high resting
Cl conductance and low membrane potential [127]. The second pathway for KCl efflux
is the conductive pathway. This is used by cells such as astrocytes which demonstrate a
much faster RVD and have a low basal Cl permeability [48, 127, 133]. During RVD,
astrocytes increase their permeability to Cl so much that it surpasses their permeability
to K+. Potassium is then the rate limiting step in RVD. This was revealed by PasantesMorales et al. by pharmacologically increasing cation permeability and showing greatly
accelerated RVD [127].
Chloride can exit the cell through a channel known as the volume-sensitive
outwardly rectifying (VSOR) Clֿ channel. Characteristics of this channel include
activation by intracellular ATP and sensitivity to Mg2+ that is free in the cytosol [120]. A
critical activator of VSOR Cl channels during cell swelling, is H2O2 produced via
NADPH oxidase [156, 163]. Regardless of the means of activation, the chloride current
activated by cell swelling is relatively similar in all cell types. The Cl current
established by VSOR Cl channels is outwardly rectifying and demonstrates
depolarization-dependent inactivation [156].
RVD is also accomplished using organic osmolytes such as free amino acids,
polyhydric alcohols, and methylamines. The common amino acids effluxed from cells in
the brain during RVD are taurine, glutamate, and aspartate [141]. Taurine efflux from
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astrocytes during hypoosmotic exposure is mediated by a Cl dependent diffusion
pathway and not a reversal of the energy dependent taurine carrier which brings taurine
into the cell [141]. The diffusion pathway for amino acids is permeable to acidic amino
acids and those that are neutral (α- and β-amino acids), it is not permeable to basic amino
acids such as arginine and lysine [126, 128, 141].
Similar to astrocytes, C6 cells use organic osmolytes to regulate their volume,
though they cannot account for RVD alone. The amino acids that are effluxed during
hypoosmotic exposure are taurine, aspartate, glutamate, and alanine. According to
Mountain et al., there is a low intracellular concentration of amino acids in C6 cells and
consequently a small release of these compounds [116].

Necrotic Volume Increase
When a swelling cell is unable to regulate its volume it eventually bursts, a
process termed necrotic volume increase (NVI). Swelling during NVI occurs in
cytoplasmic organelles as well as the cytoplasm itself [25]. In a whole animal, rupturing
of cells causes an inflammatory response in the surrounding tissue [17, 122]. The
irreversible step of NVI is ATP depletion. In ROC-1, a rat oligodendrocyte-rat glioma
hybrid, irreversible depletion of ATP below 50% causes necrotic cell death [80]. ATP
depletion also causes the other characteristic signs of necrosis such as bleb development,
cell swelling, plasma membrane disruption and increased intracellular Na+ concentrations
[17, 18, 80, 122].
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Apoptotic Volume Decrease
Apoptosis is programmed cell death that occurs in most cell types [161].
Apoptosis occurs in multi-cellular organisms triggered by a set of morphological,
biochemical or genetic characteristics [25, 26, 103, 161]. This process allows a cell to be
eliminated from a tissue without disrupting the surrounding tissue via inflammation [25,
93]. Apoptosis is an ATP-dependent pathway that allows an organism to get rid of old or
unwanted cells. Apoptosis requires high ATP levels, and low levels of intracellular Na+
[17, 97, 123]. Once apoptosis is activated, the cells undergo characteristic changes which
are cell shrinkage (apoptotic volume decrease), nuclear condensation, cleavage of DNA,
RNA, and proteins by endonucleases, mitochondrial depolarization, and eventual
blebbing of the cell membrane causing apoptotic body formation [25, 26, 93].
One of the first events that occur when a cell undergoes apoptosis is apoptotic
volume decrease (AVD). The channels activated during AVD are similar to the channels
activated to facilitate RVD during exposure to hypoosmotic media [161]. If volume
reduction is prevented by blocking VSOR Clֿ channels or volume regulatory K+
channels, apoptosis is prevented [93, 103, 161]. The difference between RVD and AVD
is that RVD occurs when cells are exposed to hypoosmotic solutions and is used to
regulate its volume and AVD occurs in isoosmotic solutions when a cell is destined to die
[143]. If a cell is to undergo apoptosis then it must override or turn off the cell’s RVI
mechanism as it continues to shrink.
Cell death via apoptosis in C6 cells, as well as other glial cell lines, seems to be
mediated by phosphorylation of ERK and an increase in p53 [35]. Hydrogen peroxide
causes the phosphorylation of ERK through the growth factor receptor and Ras signaling
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pathways [96]. Cells exposed to H2O2 have increased p53 expression that correlates with
apoptotic cell death. When glial cells are exposed to ROS, cytochrome-c is released from
mitochondria, possibly due to mitochondrial membrane depolarization. This release
activates MDM-2 which is a caspase-3-like molecule that regulates p53. MDM-2 is
cleaved causing it to lose its ability for degradation of p53, thus there is an increase in
p53. p53 which is normally located in the nucleus, moves to the cytoplasm, mainly in the
mitochondria where it activates caspases that leads to apoptosis within the cell [24, 87].

Redox Reactions
Oxygen is a critical part of life for higher organisms. It is necessary for aerobic
respiration which provides the greatest amount of cellular energy for most cells. While
producing energy aerobic respiration also can produce free radicals as a byproduct. Free
radicals are molecules that have an unpaired electron and typically a carbon, oxygen, or
nitrogen base. Within the mitochondria, oxygen free radicals are produced at complex I
and III of the electron transport chain [21]. Other sites of free radical production within
the cell are NADPH oxidase complex, xanthine oxidase, and nitrous oxide synthase.
Oxygen radicals react readily with metals, oxidants, and reductants yielding a gamut of
reactive species. Not all of the products formed by these free radical reactions are in
themselves free radicals [92]. For example, hydrogen peroxide (H2O2), which is not a
free radical, is formed when the free radical, superoxide, interacts with the enzyme
superoxide dismutase (SOD) [55, 137]. Reactive oxygen species (ROS) are molecules
that are made from oxygen free radicals and are highly reactive.
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Oxygen
Redox reactions are a group of reactions in inorganic chemistry that cause the
oxidation and reduction of reactants. Some redox reactions occur via the movement of
electrons. A molecule is oxidized as it gains an electron and it is reduced as it loses an
electron in two half-reactions, as one molecule gives an electron to another molecule.
The redox potential, or the molecules electronegativity E°, is the affinity that a substance
has for electrons compared to the affinity for electrons of hydrogen. The direction in
which the reaction proceeds depends on the electronegativity of the reaction; the more
positive the E° the more readily an oxidation reaction occurs. Redox potentials for the
addition of electrons to oxygen are as follows:
O2 + eֿ → ۠۟O2

E° = - 0.33 V

[2]

۠۟O2 + eֿ + 2H+ → H2O2

E° = + 0.89 V

[3]

H2O2 + eֿ + H+ → H2O + HO۠

E° = + 0.38 V

[4]

HO۠ + e۠ + H+ → H2O

E° = + 2.31 V

[5]

In the first equation above, the E° for the oxidation of oxygen is negative so a single
electron is not easily given to molecular oxygen to make superoxide. But, adding the
second, third and fourth electrons as seen in the last three equations is favorable [58].
Once superoxide is formed it can spontaneously act as an oxidant (+ 0.89 V) by adding
an electron or a reductant (+ 0.33 V) by donating an electron depending on the redox
potential of the total reaction [21, 58, 169]. Many cells use superoxide to make other
forms of ROS within the cell. They are able to first make the superoxide and then use the
superoxide to act as oxidants or reductants as the cell needs to make compounds such as
H2O2.
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ROS
Reactive oxygen species (ROS) are a broad group of reactive molecules within
the cell. Most of the molecules that make up this group are free radicals. There are a few
ROS that originate from oxygen free radicals, but are not in and of themselves free
radicals, such as H2O2 [92]. Examples of ROS are hydrogen peroxide (H2O2), superoxide
(۠۟O2), hydroxy radical (۠OH), and nitric oxide (NO) [58]. ROS act within the cell as a
second messenger, but the biological role of each ROS is dependent on its
electronegativity. Relatively speaking H2O2 and superoxide are less reactive than
hydroxy radical and therefore have different roles within the cell. Superoxide and H2O2
act as better cellular messengers because they do not react as readily with the first organic
compound that they come in contact with. Hydroxy radical, on the other hand, has a
greater potential to cause cellular damage because it readily reacts upon initial contact of
an organic compound.
The most common ROS produced within the cell are superoxide molecules.
These free radicals do not readily move through lipid membranes because of their
negative charge. The production of superoxide is spontaneous during cell metabolism,
especially in electron rich environments, such as the electron transport chain [21, 118].
By itself, superoxide is only moderately reactive, but it is readily reduced or oxidized into
molecules that are highly reactive. Superoxide is the starting molecule for the formation
of many different ROS shown below [21].
۠۟O2- + ۠۟O2 + 2H+  H2O2 + O2

Dismutase Reaction

[5]

۠O2 + H2O2  ۠OH + OH + O2

Harbor-Weiss Reaction

[6]

Fe2+ + H2O2  ۠OH + OH + Fe3+

Fenton Reaction

[7]
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۠O2 + Fe3+  O2 + Fe2+

Fenton Reaction

[8]

Though superoxide is the most common form of ROS produced in the cell, it is
not commonly used as a cellular signal. Superoxide is converted to other forms of ROS
by the cell to be used as a cellular signal. The form of ROS that is most often used as an
intracellular signal is H2O2. Two molecules of superoxide spontaneously convert to H2O2
and molecular oxygen (equation 5), but this reaction is accelerated by superoxide
dismutase (SOD) [118]. Hydrogen peroxide is not a radical, has no charge, and is similar
in size to molecular oxygen. These characteristics allow H2O2 to freely move across the
membrane [118]. Once H2O2 enters the cell it can readily react with cysteine residues,
allowing H2O2 to act as a second messenger in many cellular processes [92]
Another form of ROS produced in cells is hydroxy radical. This molecule is
formed when H2O2 oxidizes a transition metal (equation 7) or when H2O2 reacts with
superoxide (equation 6). Superoxide reacts with H2O2 via the Haber-Weiss reaction, the
sum of equations 7 and 8 [21, 58, 118]. This reaction uses a transition metal catalyst to
convert superoxide and H2O2 to hydroxy radicals [118]. Hydroxy radicals are very short
lived typically and react with the first molecule they contact. Due to its reactivity, ۠OH
has the greatest potential of all the ROS to cause cellular damage [118]. Hydroxy radical
can irreversibly cause lipid peroxidation, DNA damage, and protein oxidation [58].
Other ROS such as nitric oxide (NO) are formed independently of the equations
above. Nitric oxide is produced by nitric oxide synthase (NOS). NADPH donates
electrons to the amino-terminal of L-arginine forming L-citrulline and NO. NO reacts
similarly to superoxide in that it is not readily reactive with biomolecules, but reacts with
other free radicals [118]. When NO reacts with free radicals it generates less reactive
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molecules which allows NO to act like a free radical scavenger. At physiological
concentrations NO acts as a second messenger within the cell. Similar to H2O2, NO can
pass through the membrane thereby transferring signals to neighboring cells. But, if NO
is produced in high amounts with superoxide the two molecules will combine to form
peroxynitrate. Peroxynitrate reacts with CO2 or may get protonated forming
peroxyocarboxylate and peroxonitrous acid, respectively both of which are toxic to the
cell by attacking tyrosine residues in proteins [118].
Once a free radical is formed by a cell it continues to react and form new free
radicals until it comes to interact with another free radical or an antioxidant. When the
free radical comes in contact with another atom, the extra electron on the free radical
attracts an electron from the other atom. This forms a stable compound and a free radical
that then reacts with another atom. The series of reactions that continues to form new
free radicals is known as the propagation phase. If two free radicals react with each other
or if a free radical interacts with an antioxidant, then the propagation phase is terminated.

Antioxidants
The redox state within a cell is highly regulated. Free radicals are important for
cellular functions, but in high concentrations they can harm the cell. One way in which
the cell protects itself from the harmful effects of free radicals is by producing
antioxidants. Antioxidants bind with free radicals within the cell and render them
ineffective and unreactive. The effectiveness of an antioxidant is dependent on the
stability of the free radical it forms.
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A common lipid soluble antioxidant in mammalian cells is vitamin E. Vitamin E
effectively protects DNA from free radical attack by scavenging lipid peroxyl radicals
and terminating the propagating redox chain reaction that produces DNA-damaging
products. Another protective action of vitamin E is via direct inactivation of ROS [13].
Vitamin E prevents free radical damage by transferring hydrogen to the propagating
chain. This creates a vitamin E free radical, which is stable. Free radicals formed by the
antioxidants must be more reactive with other free radicals than they are with biological
molecules. This is important so that the free radicals formed by the antioxidants do not
cause cellular damage. Once the cellular free radical reacts with an ascorbate radical
(asc·) the reaction is terminated [170]. For example, trolox C, a vitamin E analogue,
donates a hydrogen atom from the hydroxyl group of the chromanol ring on the trolox C
molecule. This hydrogen reacts with the propagating free radicals to yield a phenoxyl
radical. The phenoxyl radical oxidizes ascorbate and other biomolecules to radicals
[158].
Of the vitamin E analogues, trolox C is the most hydrophilic. This property is
important for trolox C to be sufficiently soluble in aqueous solutions to allow it to move
into the cell. Trolox C has a structure similar to the most common vitamin E analogue in
mammals, α-tocopherol [158].
Antioxidants scavenge for free radicals within the cell by forming stable free
radicals. The free radical that the antioxidant forms then reacts with other free radicals
found within the cell. However, when the antioxidant is present at high concentrations
within the cell the scavenging free radicals formed by the antioxidant can themselves
cause damage to the cell. The way in which the antioxidant damages the cells is it acts
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as a pro-oxidant, oxidizing DNA, proteins and lipids. High concentrations of
antioxidants can damage the cell in similar ways as high concentrations of ROS. Vitamin
E, like many other antioxidants, has been shown to act as a pro-oxidant when present in
high concentrations [158]. Vitamin C (ascorbate) is a water-soluble antioxidant that
scavenges reactive oxygen and nitrogen species [13]. Ascorbate forms an ascorbate
radical (asc·) which reacts with other free radicals within the cell terminating the
propagation of the free radials and protecting the cells.

Biochemical Importance
Depending on the redox state of the cell, ROS can either act as intracellular
messengers or produce harmful effects in cells. Most ROS are good signaling molecules
because they are easily synthesized, highly diffusible, easily degraded, and present in
most cell types [59]. Thus, ROS act as intracellular signals in areas such as activation of
transcription factors, inducing apoptosis, activating or deactivating ion channels, and
inducing an immune response [92, 96, 108, 110, 129, 143, 144]. Because of the reactivity
of ROS, antioxidant systems within the cell are needed to protect the cell from the
potentially harmful effects of ROS. When antioxidant systems within the cell are not
able to maintain physiological concentrations of ROS cell toxicity may occur.
ROS are unique as intracellular signals because they are highly reactive,
interacting with most organic molecules within the cell [129]. Normally intracellular
signals are very specific, reacting with one element of a signaling pathway. But ROS are
able to act as intracellular signals by modifying the redox potential of the cell [92]. The
intracellular redox potential moves towards oxidation when the level of the ROS
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increases or the level of antioxidants decreases below physiological range. This may
cause irreversible damage to macromolecules within the cell [58] including lipid
peroxidation, and damage to DNA [3, 36, 101, 106]. Some diseases have been
associated with altered redox state including Alzheimer’s disease, Parkinson’s disease,
enteric disorders, diabetes insipidus, diabetes mellitus, Huntington’s disease, and
amyotrophic lateral sclerosis [6, 66, 115, 140].

Sources of ROS
The understanding of free radical production and function within cells has
changed over the past few years. Free radical production was first discovered as a
byproduct of aerobic respiration, but recent research has established that free radicals are
a necessary part of cell function [43]. In order for ROS to act as a cell signal their
production must be regulated by the cell, they must have an action on the same or nearby
cell, and the ROS must be removed to eliminate the signal [62]. The major sites of
intracellular ROS production that will be discussed are NADPH oxidase, mitochondria,
xanthine oxidase, and nitric oxide synthase.

NADPH Oxidase Complex
NADPH oxidase was discovered as the location of ROS production in phagocytic
cells. This production of ROS is known as a respiratory burst, and is used by the
phagocytic cell to generate powerful oxidants as an immunological mechanism. NADPH
oxidase reduces molecular oxygen to superoxide which destroys microorganisms [45].
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NADPH oxidase is composed of two pools of peptide components located in the
cytosol and the other two are membrane components. When the components of the
complex are separated, NADPH oxidase is dormant, but when stimulated the components
come together at the plasma membrane and the complex is activated. The cytosolic
components are made up of p67phox / p40phox and GTPase Rac1/Rac2 [56]. The
membrane bound components are p47phox and gp91phox. Two of the components, p47phox
and p67phox, may have NADPH and FAD binding sites, but the exact function of the
remainder of the components is still unknown [78]. In phagocytic cells the cytosolic
components move to the plasma membrane when cells are exposed to microorganisms or
inflammatory mediators. When the cytosolic components bind to the membrane
components at the membrane, NADPH oxidase is activated [125]. Arachidonic acid
(AA) interacts with the cytosolic component, p47phox and causes it to undergo a
conformational change. This change in p47phox opens up a binding site for interaction
with p22phox, a membrane-bound component. Phosphorylation of p47phox also plays a role
in its activation. The two membrane bound components come together to form a
stabilized complex known as flavocytochrome b558. Once this complex is assembled it
acts as the catalytic core that allows for the transfer of electrons from NADPH to
molecular oxygen thus reducing extracellular O2 to O۟2ֿ [57]. Nonenzymatic O۟2ֿ
dismutation quickly occurs forming H2O2; however, superoxide dismutase can accelerate
this reaction. Most superoxide dismutases are found outside the cell; therefore, the
majority of the conversion of O۟2ֿ to H2O2 takes place in the extracellular space [56].
Like many other cell types, astrocytes use NADPH oxidase to produce ROS
[100]. Under hypoosmotic conditions NADPH oxidase is activated [135]. Swelling of
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the astrocytes activates PKC which then causes rapid serine phosphorylation of the
p47phox component [135]. Hypoosmotic swelling also increases intracellular calcium
levels which also play a role in the activation of NADPH [2]. This occurs because
swelling of astrocytes is sufficient to induce serine phosphorylation of p47phox causing
NADPH-dependent ROS production [2, 135].

Mitochondria
A second major source of ROS is the electron transport chain (ETC) in the
mitochondria. The ETC oxidizes the reduced cofactors, FADH2 and NADH, by
transferring electrons to oxygen through a series of steps. The free energy from the
oxidation-reduction reactions in the ETC is used to form a membrane pH gradient across
the inner mitochondrial membrane which provides energy for ATP synthesis [10, 44].
During this process, some molecular oxygen may be reduced thus forming a superoxide.
Approximately one to two percent of oxygen consumed systemically is converted to ROS
in the mitochondria [146].
The ETC is made up of 4 complexes, complex I, II, III, and IV. Electrons are
carried from the Krebs Cycle by NADH and FADH2. NADH moves 2 electrons to
complex I which then moves them to the ubiquinone pool in the intermembrane space.
Complex II receives electrons from FADH2 and moves them to the ubiquinone pool by an
iron-sulfur center. The electrons continue from the ubiquinone pool to complex III where
they are transferred to cytochrome c and then to complex IV. When the electrons reach
complex IV they are transferred to molecular oxygen. Electrons are transferred from
reactants with more negative reduction potentials to an electron acceptor that has a more
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positive reduction potential. Each of these complexes is only capable of transferring one
electron at a time to the next site along the ETC.
Similar to NADPH oxidase, mitochondrial ETC can form superoxides by
reducing molecular oxygen. The two major sites in the ETC of the mitochondria that are
responsible for the monoelectronic reduction of oxygen are complexes I and III. These
two complexes have a slight tendency to transfer electrons to oxygen instead of the next
electron acceptor in the ETC causing the reduction of molecular oxygen and the
formation of superoxide radical. The rate of the ROS production in the mitochondria is
highly dependent on the mitochondrial membrane potential. When the respiratory rate
decreases because of a decrease in intracellular ADP concentration, there is an increase in
the mitochondrial membrane potential which causes an increase in the production of ROS
[111].
Only a single electron can be transferred at a time from an electron donator to the
electron acceptor. There are two pools of ubiquinol, one accepts electrons from complex
I and the other accepts electrons from complex III. Ubiquinol can carry two electrons
from complex I and III; transferring the electrons one at a time to the next electron
acceptor. Movement of one electron at a time to components such as NADPH,
ubiquinone, and cytochrome c allows for free radical formation. Specifically this occurs
as NADH dehydrogenase and ubiquinone transfers one electron to an iron-sulfur cluster
and forms semiquinone. The semiquinone then oxidizes forming superoxide [8].
Most ROS production during normal respiration occurs at complex I, NADHubiquinone oxidoreductase. Complex I is responsible for catalyzing the transfer of
electrons from NADH to ubiquinone. During aerobic respiration, NADH gives two
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electrons and two protons to complex I. Complex I then transfers the electrons to
ubiquinone, a lipid soluble carrier. The energy released in the transfer of electrons is
preserved by the movement of four protons across the membrane to the mitochondrial
intermembrane space. This movement of protons sets up a proton gradient across the
mitochondrial inner membrane. During this process some electrons are transferred to
molecular oxygen forming superoxide.
Another location of ROS production in the mitochondrial ETC is complex III,
ubiquinol-cytochrome c oxidoreductase. This complex is involved in the movement of
two electrons and four protons. Complex III moves one electron at a time from
ubiquinol, which contains two electrons that it can donate, to cytochrome c, a watersoluble electron carrier that is in the intermembrane space. During the movement of
electrons to cytochrome c, some are transferred to molecular oxygen to make superoxide.

Xanthine Oxidase
Another major source of ROS is xanthine oxidase. Xanthine oxidase contributes
very little to ROS production in a normally functioning cell, but has been shown to be a
source of ROS during oxidative stress [43]. Xanthine dehydrogenase (XDH) and
xanthine oxidase (XO) are reversibly convertible within the cell. XDH can be converted
to XO by oxidizing eight cysteine residues to four cysteine residues with pyrimidines or
oxidized glutathione [19, 64]. This reaction can be reversed by a reducing agent like
dithiothreitol [7]. XDH and XO can be used to reduce NAD or molecular oxygen,
respectively. The redox state of the cell oxidizes or reduces the enzyme forming XO or
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XDH, respectively. Thus, when cells are at an oxidized redox potential, XO will be
formed and cause formation superoxide from molecular oxygen [63].
The reaction of xanthine oxidase begins with the conversion of hypoxanthine
which is converted to xanthine and uric acid. When xanthine is reduced to uric acid, two
electrons are given to xanthine oxidoreductase (XOR) which reduces molybdopterin
(Mo) VI to Mo(IV) forming XOR2e--Mo(IV). When xanthine oxidase is fully reduced it
has the ability to donate six electrons. The first four electrons are donated to 2 oxygen
molecules to make hydrogen peroxide (H2O2). The last two electrons are donated one at
a time to oxygen creating superoxide (O2.-). Thus fully reduced xanthine oxidase has the
capability of making two H2O2 and two O2.- [63, 69].
The production of ROS via xanthine oxidase is largely due to oxidative stress.
The exact mechanism for the activation of xanthine oxidase is unclear, but it is proposed
by Kayyali et al.’s work that phosphorylation of XOR in hypoxic situations is associated
with enhanced enzyme activity [22, 81].

Nitric Oxide Synthase
Nitric oxide synthase (NOS) is a dimeric enzyme that is only active when the two
subunits come together. Activated NOS is capable of making the free radical nitric oxide
(NO). This enzyme works by oxidizing the terminal guanidinium nitrogens of L-arginine
forming NO and L-citrulline. This reaction is a two step process. In the first step Larginine is oxidized with two electrons forming N-hydroxy-L-arginine (NOHA). The
second step takes NOHA and further oxidizes it to form NO and L-citrulline. The redox
reaction uses the enzyme NOS to transfer electrons from NADPH to O۠2. There are three
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main isoforms of NOS, endothelial (eNOS), neuronal (nNOS) and
immunological/inducible (iNOS). Each of these comes from individual genes, are
regulated separately and are located in different places within the cell [58, 154]. Studies
have shown that eNOS and nNOS are 60% identical, eNOS and iNOS are 50% identical,
and iNOS and nNOS are 50% identical [60]. Another type of NOS is mitochondrial NOS
(mtNOS) which is similar in form and function to nNOS. Stimulation of mtNOS changes
the rate of oxygen free radical production in the mitochondrion [46, 142].
Knowles et al. [89] found that NO synthases in the normal brain are calcium
dependent. NOS in the brain is inactive at resting free Ca2+ concentrations, but becomes
fully active when the Ca2+ concentration increases. Since eNOS and nNOS are both Ca2+
dependent, either of these could be activated in Knowles et al.’s experiments. The form
of NOS that is typically found in astrocytes is iNOS which is over 90% identical to other
forms of iNOS found in mouse macrophages, rat hepatocytes, and rat smooth muscle
[60]. The inducible form of NOS is calcium-independent [60, 104]. During pathological
situations evidence suggests that glial cells are also capable of expressing calciumdependent eNOS [89, 104]. Similarly there are two types of NOS isoforms found in C6
cells, eNOS that is active in pathological situations and iNOS [16, 49, 104].
Nitric oxide is functionally important during immune responses in glial cells,
including C6 cells. Superoxide release from C6 cells stimulates NO formation via NOS.
When SOD increases, changing superoxide to hydrogen peroxide, the NO levels in the
cell decrease [104]. Barna et al. found that there is an increase in the eNOS expression in
astrocytes when neurons are infected with vesicular stomatitis virus (VSV) [16].
Astrocytes thus increase their production of NO, killing the virus so that the virus does
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not infect surrounding cells. It is also possible for NO to diffuse out of the cell to
neighboring infected cells in order to kill the virus. They also found that the neurons, not
the astrocytes, were infected with the virus when astrocytes increased their NO
production. The neurons were signaling the astrocytes to increase eNOS expression for
NO production. The NO then diffused into the neurons to kill the virus [16].

Other ROS Producers
While NADPH oxidase, mitochondrial ETC, xanthine oxidase, and NOS are
responsible for most of the ROS production in cells, other sources of ROS include
oxidation of dopamine [43] and activity of peroxidases [62].

Cell Signaling
ROS are able to act as intracellular signals because they can diffuse across short
distances, are easily synthesized, and easily degraded [59, 92]. Many were skeptical of
ROS acting as an intracellular signal because their high reactivity cause them to interact
with the first organic molecule to which they come in contact [129]. However, we now
know that ROS can activate pathways which lead to the phosphorylation of molecules
such as protein kinases, protein phosphatases, phospholipases, ion channels, and small
GTPases [129].

Transcription Factors
Transcription factors are important gene regulators within the cell that are used to
control the rate of transcription of specific genes. When under physiological stress, such
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as viral or bacterial attacks, cells must produce certain proteins to fight these attacks.
ROS act as intracellular signals in these conditions to activate transcription factors via
oxidation of cysteine residues. The oxidation of sulphydryl groups forms disulphide
bonds and results in intra or inter-molecular bonds [37].
Two transcription factors known to be activated by ROS are nuclear factor-ҝB
(NF-ҝB) and activator protein-1 (AP-1) [144]. NF-кB activates genes critical for early
cellular defense reactions. Similarly, AP-1 is activated to regulate stress response genes
that control cellular proliferation and apoptosis [59]. NF-ҝB is typically found in the
cytoplasm of a cell where it is inactivated by binding IҝB [62]. Activation of NF-ҝB is
accomplished by phosphorylating IҝB which releases it from NF-ҝB [50, 59, 62, 65,
144]. Then NF-ҝB is active and able to move to the nucleus to begin transcription [62].
The ROS molecule, H2O2 is an effective activator of NF-ҝB [59, 144]. The most
probable way in which H2O2 activates NF-ҝB is through activation of a kinase that then
phosphorylates IҝB [59].
AP-1 is made up of a homodimer, Jun, and a heterodimer, Fos. Both dimers are
present within the cell, but dormant until phosphorylated. Phosphorylation of AP-1
causes the two dimers, Jun and Fos, to come together. This provides a binding site for
the DNA sequence containing the appropriate AP-1 sites and thus initiates transcription.
Due to the presence of two sites on the complex that are phosphorylated by interaction
with ROS, activation of AP-1 is highly dose dependent. Phosphorylating AP-1 a second
time greatly enhances its activity. Similar to NF-ҝB, the redox state within the cell
affects the phosphorylation status of AP-1. During oxidative stress AP-1 is
phosphorylated at both sites on the complex which causes greater activation of AP-1
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during these conditions [59, 144]. Many cells use the redox state to activate both AP-1
and NF-кB including astrocytes and more specifically C6 cells [75, 85, 95, 99, 109].
Another role of NF-кB and AP-1 in astrocytes and C6 cells is the production of
NO. NF-ҝB and AP-1 initiate NO production by activating iNOS. Synthesis of NO is
important in immune response by acting as an antitumor agent [85, 95].

Ion Channels
ROS also function as ion channel regulators. They can do this in several ways:
direct modification of the channel proteins to an active state, activating other signaling
mechanisms that in turn activate the channel, or changing gene expression of the channel
proteins [110].
In astrocytes, H2O2 activates channels that increase intracellular Ca2+ [6, 72].
Through this mechanism, hydrogen peroxide may modify physiological functions such as
secretion, synaptic plasticity, gene expression, muscle contraction, channel activation,
cell proliferation, and cell death [6, 72, 152]. For example, H2O2 acts by inducing
phosphorylation of PLCγ1. This then activates subsequent messengers which increase
intracellular calcium levels and activate protein kinase C [72].

Apoptosis
Apoptosis or programmed cell death is a type of cell death that is controlled by
mechanisms within the cell. It can be used to remove unwanted cells from tissue without
disrupting the surrounding tissue [143]. This form of cell death, which has been found in
many different cell types [25, 93, 161], occurs in two defined stages. The first stage of
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apoptosis is characterized by nuclear and cytoplasmic condensation. Thus, the cytoplasm
shrinks, as does the nucleus, eventually breaking up into small membrane-bound
fragments known as apoptotic bodies. Another characteristic of apoptotic cell death is
the externalization of phosphatidylserine. Phosphatidylserine is only found on the inside
of the cell membrane, but as cells become apoptotic they flip the phosphatidylserine to
the outside of the membrane. Experimenters have used this as an early indicator of
apoptosis by using a fluorescent dye, annexin V, to bind to the external
phosphatidylserine molecules [134]. The second stage of apoptosis occurs when
apoptotic bodies are phagocytosed by neighboring cells [143]. Some of the triggers for
apoptosis are hormones or growth factors during development, organismal protection
through the immune system by killing off viral or bacterial infected cells, or in response
to cell injury [143]. Apoptosis uses ATP to control characteristic events such as cell
shrinkage, apoptotic volume decrease, nuclear condensation, DNA, RNA, and protein
cleavage by endonucleases, mitochondrial depolarization, and eventual blebbing off the
cell membrane, forming an apoptotic body [17, 25, 26, 93, 97, 123].
Apoptosis can be initiated by intercellular or intracellular signals. Intercellular
signaling of apoptosis occurs via transmembrane receptors called death receptors. These
receptors bind to specific signals, death signals, such as tumor necrosis factor that induce
the apoptotic pathway. When the death signals bind to the extracellular portion of the
receptor it induces activation of caspases 8 and 9. These 2 caspases activate the cascade
of events that will end in apoptotic cell death.
Intercellular signaling of apoptosis causes the release of cytochrome c from
mitochondria and a protein factor called Apaf-1. These signals activate caspase 9
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initiating the apoptotic cascade [10]. Some intracellular signals known to play a role in
inducing apoptosis include an increase in intracellular calcium, activation of protein
kinases A and C, and alterations in gene expression [143]. The presence of ROS can
increase the probability that the cell will become apoptotic. This action of ROS may be
mediated by ERK, p53, NF-қB, and caspase-11 [87, 96, 157, 160].
Extracellular signal-regulated kinase (ERK) plays a role in regulating cell growth,
survival, and differentiation. Lee et al. found H2O2 increased the activation of ERK
leading to apoptotic cell death; however, the mechanism of ERK induced apoptosis is
somewhat unclear. H2O2 leads to the phosphorylation of ERK using a growth factor
receptor and Ras signaling pathway [96].
ROS also induces the accumulation of p53. During the cell cycle p53 is a critical
regulator at the G1 checkpoint. p53 stops cells that have DNA damage from entering
mitosis and induces apoptosis of the cell if the damage is irreparable. Cells exposed to
H2O2 have increased DNA fragmentation and chromatin condensation, similar to that
observed in apoptosis, and an increase in p53 expression. Thus, cells damaged by
oxidative damage tend to enter apoptosis if p53 cannot activate the repair of the DNA
[87].
An important activator for apoptosis in astrocytes is a rapid increase of
intracellular calcium. Calcium can accumulate in the cell if the Na+-Ca2+ exchanger is
reversed. This process then induces apoptosis [143, 159, 160]. Most studies show a need
for intracellular Ca2+ increase to activate apoptosis [143, 160].
Apoptosis during inflammatory responses in C6 cells is controlled by two parallel
pathways. One is a signaling cascade using caspase 11 and the other is a direct
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stimulation of apoptosis with ROS. Caspase 1, 3, and 11 are major inducers of apoptosis
[35, 157]. It has been shown that caspase 11 is crucial for the induction of apoptosis and
that it is caspase 11 that activates the down stream caspases 1 and 3 [157]. In C6 cells,
increased ERK phosphorylation and increased expression of p53 during H2O2 exposure
suggests that ROS plays a similar role in apoptosis for C6 cells compared with other glial
cell lines [35, 157].

Immune Response
When phagocytic cells such as neutrophils, eosinophils, and macrophages are
exposed to invading microorganisms they exhibit a series of fast responses which include
cytoskeletal rearrangement, motility, exocytosis of secretory granules, and activation of
NADPH oxidase. NADPH oxidase is activated to rapidly produce ROS as a means of
killing bacteria and viruses [56]. The increase in ROS is very harmful to the invading
microorganisms killing them off rapidly, but it is also harmful to the host cells. ROS in
high doses can cause damage to cells such as lipid peroxidation, protein disruptions, and
DNA splicing. Neutrophils and eosinophils produce a higher concentration of ROS than
macrophages which accounts for the greater longevity of macrophages [57].
A respiratory burst is stimulated in a macrophage by depolarization of the
membrane and an increase in intracellular free calcium. The cell then activates the
NADPH oxidase complex to produce ROS within the confines of an organelle, the
phagosome. The respiratory burst is transient. Calcium plays a role in both initiating and
terminating the respiratory burst; however, the exact mechanism of calcium is still
unclear. When initiating the respiratory burst, calcium is needed to activate p47phox
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translocation to the membrane allowing the assembly of NADPH oxidase complex.
Buffering intracellular calcium levels eliminates both enhancement and termination of the
respiratory burst and shows the vital role that calcium plays [56, 57, 73, 117].

Other Roles of ROS
Studies have determined that ROS are used to regulate intracellular pathways
involved with growth, cell division, transformation, apoptosis, and senescence [52]. For
example, protein tyrosine phosphatase has a cysteine residue that can interact with H2O2
causing activation [51]. Once activated, tyrosine phosphatase is responsible for the
control of normal growth and proliferation of the cell [51, 54].

Cell Injury
While cells are able to use low concentrations of ROS as intracellular signals,
high concentrations of ROS cause cellular damage. The level of ROS within a cell is
critical for cell survival and thus is highly regulated via rates of ROS production and the
level of antioxidants. If the concentration of ROS increases above the level which the
antioxidants can control, the cell becomes apoptotic, necrotic, or neoplastic [108]. Many
diseases also can occur if the redox state within the cell is not at physiological levels such
as Alzheimer’s disease, Parkinson’s disease, diabetes insipidus, diabetes mellitus,
Huntington’s disease, and amyotrophic lateral sclerosis [6, 66, 115, 140]. The key ways
in which uncontrolled ROS causes harm to the cell are protein peroxidation, lipid
peroxidation, and damage to DNA.
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Lipid Peroxidation
The chief components of cell membranes are polyunsaturated fatty acids [18].
Polyunsaturated fatty acids are oxidized in a normal biological process known as lipid
peroxidation [36]. But like many other processes, lipid peroxidation must be tightly
controlled within the cell. Uncontrolled lipid peroxidation causes a loss of membrane
integrity and increased membrane fluidity. In these conditions the cell is at a higher risk
of cell death [11, 36, 67].
The general mechanism for lipid peroxidation occurs in three steps, initiation,
propagation, and termination. The first step is initiation during which free radicals are
formed. The initiation step of lipid peroxidation occurs when a lipid reacts with a free
radical. Polyunsaturated fatty acids have at least one, and usually more than one,
methylene groups between cis double bonds [107]. The hydrogen atoms on the
methylene groups are readily removed to form carbon-centered free radicals which react
with molecular oxygen to form peroxyradicals.
The second step of lipid peroxidation is the propagation step. This is when the
oxygen free radical formed in the initiation step reacts with other lipids to form more free
radicals. This reaction produces another carbon centered radical which then can further
propagate the reaction. Each radical initiated can lead to many propagation steps.
The third step in lipid peroxidation is termination. Termination of lipid
peroxidation only occurs when a free radical interacts with an antioxidant like vitamin E
or combines with another free radical. When two free radicals combine they share their
unpaired electrons to form a molecule that is not a free radical [42, 107, 131].
Antioxidants reduce peroxyl radicals to hydroperoxides breaking the reaction chain and
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slowing the rate of lipid peroxidation. The concentration of vitamin E in the lipid bilayer
is therefore very important to control the amount of lipid peroxidation that occurs [130].
Neurons and glia are especially susceptible to oxidative damage because of the
large amounts of oxygen consumption, high concentrations of transition metal ions and
low concentration of antioxidants in the brain [106]. Another reason the brain is
vulnerable to oxidative damage is that it has an abundance of polyunsaturated fatty acids
which are the primary target for lipid peroxidation [105].

DNA Damage
Oxidation of DNA strands causes the strands to break, DNA-DNA crosslinking,
direct oxidation of base pairs, DNA-protein crossbridges, and base modifications [30,
106]. This can lead to altered transcription and translation levels within the cell, and
eventual cell death. Mitochondrial DNA are more susceptible to DNA damage than
nuclear DNA because there are more ROS in the mitochondria [53, 106]. Histones and
DNA repair mechanisms, not present in mitochondria, also protect nuclear DNA [106].
Once the mitochondrial DNA is damaged, the mitochondria produce more ROS causing a
chain reaction of DNA damage and ROS production [53]. DNA damage is not only
caused by ROS but also by lipid peroxidation. The peroxy radicals formed during lipid
peroxidation react with DNA and break DNA strands similar to the actions of ROS
[101].
In C6 cells, increased H2O2 production causes DNA fragmentation [166]. When
the membrane integrity is changed due to lipid peroxidation, free radicals are more able
to enter the nucleus and attack chromatin. The metal ions within the cell will also play a
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role in changing H2O2 to hydroxy radicals in or around the chromatin. Hydroxy radicals
are able to nick a single strand of DNA which can then lead to double stranded breaks.
The nicks usually occur at GG and GGG sequences within the DNA [67, 139].

Aging
Aging is a normal part of the life of an organism. ROS is known to play a role in
normal aging, and in high concentrations it also can accelerate the aging process. The
molecular theory of aging states that DNA damage and DNA errors decrease lifespan
[168]. An early sign of aging and neurodegeneration is an increase in ROS production
above the normal range to levels that are toxic to the cell [41]. The change in the redox
state within the cell alters neuronal excitability and ion homeostasis [11, 41]. These
changes in redox potential account for some of the changes that cause normal aging and
neuodegeneration, but they do not explain all of the neuronal dysfunction [41].
A disease state of a cell occurs when the intracellular redox potential is no longer
inside physiological ranges. ROS decreases lifespan by causing biological damage and
degenerative diseases associated with aging such as cancer, cardiovascular disease,
immune system dysfunction, decline in brain function, and cataracts [9, 147]. The
oxidative shift which results from excessive ROS production can produce a toxic
environment within the cell and can cause DNA damage, lipid peroxidation, and
telomerase shortening resulting in senescence of the cell [9, 41, 148, 164]. When ROS
causes shortening of the telomerase it signals the cell to exit proliferation and remain in
the G1 phase. The rate of telomerase shortening is increased in cells that are exposed to
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mild hyperoxic environments where intracellular ROS is increased [164]. This suggests
that a shift in the redox potential in cells will result in the cell entering senescence early.
DNA damage is normally repaired immediately or cell division ceases, but not all
of the lesions are repaired [3, 9]. As an organism ages the amount of unrepaired DNA
lesions and mutations increase. According to the molecular theory of aging this increase
in damaged DNA leads to the shortening of the lifespan of the organism [3, 9].

Summary of Study
Cells swollen by exposure to hypoosmotic conditions must regulate their volume
for survival. The activation of RVD mechanisms are not completely understood.
Mechanisms that seem to play a role in the activation of RVD are ROS production and
activation of extracellular purinergic receptor by extracellular ATP. ROS produced
during hypoosmotic swelling and/or the purinergic receptor activation then activate
VSOR Cl channels and allows the cells to begin RVD. Overproduction of ROS can
cause cell death either by apoptosis or necrosis. Thus in order for the cell to benefit from
the ROS production the cell must tightly control how much ROS is produced. Many
studies have determined that ROS acts as an intracellular signal in a gamut of cell types.
This study was designed to determine if ROS was produced during hypoosmotic
exposure in a rat gliomal cell line (C6 cells) and if that ROS was produced at a high
enough concentration to cause cellular injury. I also explored interaction between ROS
production and ATP release during hyposmotic exposure.

34

II. Specific Aims:
Ionic gradients across the plasma membrane are critical for proper cell function.
When cells are exposed to hypoosmotic conditions and excess water moves into the cell,
the resulting alteration of ion concentrations within and around the cell can have
detrimental effects. To recover from osmotically induced changes in cell size, volume
regulatory mechanisms are initiated in response to signals which may include the release
of ATP and an increase in the rate of production of reactive oxygen species (ROS). In
considerable amounts, ROS also may cause injury and cell death. Thus, I hypothesize
that when cells swell due to exposure to hypoosmotic conditions a resulting increase in
ROS production leads to cytotoxicity and death. I will directly test this hypothesis by
examining mechanisms of hypoosmotic-induced ROS production in rat glioma C6 cells
and determine if swelling-induced oxidative stress leads to cellular injury. I also will
examine the role that extracellular ATP plays for increased ROS production.

Specific Aim I
I hypothesize that C6 cells swollen in hypoosmotic conditions increase their
production of ROS via activation of NADPH oxidase. While swelling the cells in
hypoosmotic conditions, I will measure the rate of intracellular ROS production using a
spectrofluorometer and ROS-sensitive dyes. Some experiments will be carried out in the
presence of pharmacological agents to block specific producers of ROS including
NADPH oxidase and mitochondria electron transport chain.
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Specific Aim II
I hypothesize that C6 cells swollen in hypoosmotic conditions increase ROS
production via activation of extracellular purinergic receptors. I will expose the C6 cells
to hypoosmotic conditions and measure the release of ATP. I also will examine the effect
of ATP exposure on ROS production in isoosmotic and hypoosmotic conditions.

Specific Aim III
I hypothesize that swelling-induced increased ROS production increases the
probability of cell death. I will determine the magnitude of cell death by measuring
release of lactate dehydrogenase and with cytochemical markers of cell injury and death.

These studies will examine the relationship between the ROS production and
volume regulation. It will further our understanding of the regulation of the NADPH
oxidase and mitochondrial ROS generating complexes in glial cells and their potential
role in the regulation of cell volume and production of cell injury. This information will
provide insight into cell signaling process of cells exposed to hypoosmotic conditions.
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III. Materials and Methods:
Materials
5-(and-6-)-dichloroddihydrofluorescein diacetate (DCFDA), and annexin V came
from Molecular Probes (Eugene, OR). Trypsin, trypan blue, horse serum, fetal bovine
serum, penicillin, and streptomycin came from InVitrogen (Grand Island, NY). Trolox C
came from Aldrich Chemical Company (Milwaukee, WI). All other chemicals including
sodium bicarbonate, poly-L-lysine hydrochloride, carbenoxolone, dibenziodolium
chloride (DPI), ascorbic acid, rotenone, oligomycin, in vitro lactate dehydrogenase based
toxicity assay kit (LDH kit), bicinchoninic acid kit for protein determination, ATP, and
hydrogen peroxide came from Sigma-Aldrich (St. Louis, MO) or Fischer Scientific
(Hanover Park, IL).

Glial Cultures
Frozen C6 cells in suspension were obtained from American Type Culture
Collection (Manassas, VA). We quickly thawed the cells to 37 ºC and plated them onto a
25 cm2 flask containing 3 ml of growth medium consisting of Ham’s F-12 Kaign’s
medium (Ham’s F-12K) containing 2 mM L-glutamine (Sigma-Aldrich, St. Louis
Missouri) plus 15% horse serum, 2.5% fetal bovine serum, 50 units/ml penicillin, and 50
µg/ml streptomycin. Ham’s F-12K medium was made from powder and was
supplemented with 1.5 g/L sodium bicarbonate according to the manufacturer’s
directions. We first prepared aliquots of cells for freezing so that additional C6 cells
would be available for later study. Cells were grown until confluent and then were
removed from the dish and replated onto 10, 25 cm2 flasks. To remove the cells from the
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flask for replating, we first replaced the growth medium with 0.25% trypsin in Hank’s
balanced salt solution. When the cells had been loosened from the culture surface (5 - 15
min) we added complete medium to inactivate the trypsin. The resulting cell suspension
was centrifuged for 5 min at approximately 300 x g and the supernatant medium with
trypsin was decanted and replaced with fresh growth medium for plating onto new
culture flasks. After these cell cultures had grown to confluence, the cells were removed
with trypsin as described above, centrifuged, and resuspended in complete growth
medium (1 ml per culture flask) containing 5% dimethylsulfoxide as a cryoprotectant.
The suspension was divided into Nalgene cryogenic vials (Rochester, NY), slowly cooled
in stages to 4 ºC, -20 ºC and -70 ºC and then placed in liquid nitrogen for long-term
storage.
C6 cells were replated weekly to maintain cells below confluence. Cells were
plated at different densities so that experiments performed on different days of the week
used cultures of similar cell density (approximately 75% of confluence). Cells were
placed in 24-well plates or in 35 mm dishes. Some of the 35 mm dishes contained glass
coverslips. The growth surfaces were coated with poly-L-lysine hydrochloride prior to
plating the cells by treating the surfaces for 120 min with a solution of 0.05 mg/ml polylysine in sterile water. Cells were maintained at 37 ºC in an atmosphere of room air with
5% CO2. The growth medium was changed to serum-free media Ham’s F-12K plus 50
units/ml penicillin, and 50 µg/ml streptomycin 24 hours prior to experimentation.
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Reactive Oxygen Production
To evaluate the production of reactive oxygen species (ROS) by C6 cells, we
measured the fluorescence of an exogenous intracellular fluorescent dye using a
computer-controlled SLM 8000C spectrofluorometer. Cells were first incubated for 15
min with 50 µM of DCFDA in a phosphate-buffered saline (PBS) solution at 37 ºC. PBS
consisted of 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2, 3.2 mM
Na2HPO4, 0.5 mM KH2PO4, and 5.5 mM glucose (290 mOsm). Osmolality was adjusted
using small volumes of 3.0 M NaCl and confirmed using vapor pressure osmometry.
After loading the cells we moved the coverslip to the fluorescence cuvette in the
spectrofluorometer. The coverslip was placed in a Teflon coverslip holder in a standard
fluorescence cuvette (1.2 cm × 1.2 cm × 4.5 cm), and held at about 30º relative to the
excitation light path. The perfusion solution was placed into a 20 ml syringe and
delivered to the cuvette at 1 ml/min using a programmed syringe pump. The syringes
containing perfusion solution and the chamber of the spectrofluorometer holding the
cuvette were warmed in a water bath set at a temperature which maintained the cells at 37
± 1 ºC. A stainless steel tube delivered the perfusion solution to the bottom of the cuvette
under a baffle to reduce turbulence. Thus, the solution filled the cuvette from the bottom
and flowed upwards over the cells. As the perfusion solution pooled at the top of the
chamber, it was removed by continuous suction via a second stainless steel tube
positioned above a second flow baffle at the top of the cuvette [132].
The cells typically were held in the chamber for 20 min. During the first 10 min
cells were perfused with isoosmotic PBS. Then I changed the perfusion solution to an
experimental PBS solution for the next 10 min. Experimental solutions were made
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hypoosmotic (200 mOsm or 150 mOsm) by reducing the concentration of NaCl.
Pharmacological agents such as trolox C (150 µM), ascorbate (400 µM), DPI (10 µM),
rotenone (5 µM), or oligomycin (10 µM) also were added to some of the experimental
PBS solutions. When an agent was used in the hypoosmotic PBS, it also was added to
isoosmotic PBS for 5 min prior to hypoosmotic exposure.

Evaluation of Cell Death
Cell death was evaluated using trypan blue, to label necrotic cells, or annexin V,
to label apoptotic cells. DAPI was used to stain nuclei of all the cells. Serum free growth
medium was removed from the dishes and the cells were rinsed two times with sterile
isoosmotic PBS. Then the sterile experimental PBS was added to the dishes and the cells
incubated for one hour at 37 °C. I rinsed the dishes again with sterile isoosmotic PBS,
fed the cells with fresh serum-free growth medium, and returned the dishes to the
incubator. After 24-hours the cells were taken from the incubator and medium was
removed. Isoosmotic PBS was added to the cells for 5 min. Then the solutions were
changed to a 2% trypan blue solution in Hanks salt solution or annexin V diluted 1:1000
in isoosmotic PBS for 10 min. This solution was removed and the cells rinsed with PBS
before exposure to 70% ethyl alcohol for 10 min. Ethanol was removed and DAPI stain
was added to the cells at a concentration of 0.5 µg/ml in isoosmotic PBS for 10 min.
Cells then were rinsed for 5 min in isoosmotic PBS and then 5 min in distilled water.
Coverslips were then fixed to glass slides and allowed to dry for 24 hours.
The release of lactate dehydrogenase (LDH) into the growth medium was used as
a measure of cell death via necrosis following hypoosmotic exposure. LDH was
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determined in growth medium and attached cells using a commercial kit (Sigma-Adrich,
St. Louis, MO). Serum free growth medium was removed from the dishes and the cells
were rinsed two times with sterile isoosmotic PBS. Then the sterile experimental PBS
was added to the dishes and the cells incubated for one hour at 37 °C. The dishes were
rinsed again with sterile isoosmotic PBS, fed with fresh serum-free growth medium, and
returned to the incubator. The serum-free growth medium was removed 24 hr later and
saved for LDH analysis. The cells then were scraped from the dishes into 1 mL of fresh
serum-free growth medium. This solution was sonicated 3 times for 5 s. LDH was
measured after diluting 5 µL of the sonicated cell solution with 295 µL of fresh serumfree growth medium or 150 µL of the growth medium with 150 µL of fresh serum-free
growth medium. Then 600 µL of LDH assay solution was added to each diluted sample
following the directions of the assay kit. This solution was incubated in the dark for 30
min at room temperature. After this time I measured the absorbance at 490 nm using a
spectrophotometer.

ATP release
The release of ATP from cells during exposure to isoosmotic and hypoosmotic
PBS solutions was determined using a commercially available kit based on luciferin
luminescence. We designed these experiments to mimic the solution changes used for
the fluorescence studies. Cells were rinsed twice with isoosmotic PBS and then were
incubated for a total of 20 minutes in isoosmotic PBS prior to exposing the cells to the
experimental solution. When pharmacological agents were present in the experimental
solution, they also were added to the isoosmotic PBS for the last 5 min, similar to the
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procedure used for spectrofluorimetric analyses. Some solutions also contained
carbenoxolone. After treatmen, the PBS solution was removed from the cells and stored
in an ice bath until analyzed for ATP content. Cells were dissolved from the culture well
for protein measurements using 0.5 ml of 1 M sodium hydroxide for 20 min.
To measure ATP, contemporaneous standards were prepared using a 1 mM stock
solution of ATP. The amount of ATP in each sample was determined by preparing 5
standards with different amounts of ATP (0 pmols, 0.04 pmols, 0.12 pmols, 0.21 pmols,
and 0.42 pmols). The luciferin assay was prepared by combining a 1:9 ratio of ATP
assay mixture and ATP buffer from the kit. Each sample tube received 100 µL of the
diluted assay mixture for 3 min of incubation to remove endogenous ATP in the
solutions. Then 100 µL of sample or standard was added and luminescence was
measured immediately using a 1250 Luminometer (LKB Finland). Solutions were placed
in the luminometer chamber and the measurement was taken once reading the settled at a
peak height.
Protein was measured using a bivinchoninic acid kit for protein determination
according to the manufacturer’s directions. The protein content of the standards was 0
ug, 10 µg, 20 µg, 30 µg, 40 µg and 50 µg. Absorbance of each sample and standard was
determined at the suggested wavelength (562 nm) in a spectrophotometer.

Summary of Statistics:
Fluorescence data was analyzed by repeated-measures ANOVA. Comparisons of
LDH release between experimental groups were performed using Student’s t test or Z
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test. Counts of apoptotic or necrotic cells were compared with chi square analysis.
Significance was indicated for P < .05
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IV. Results
Oxidized DCF Excitation Spectra
DCFDA freely diffuses into the cell where the two acetate groups are removed by
endogenous esterases, forming 5-(and-6-)-carboxy-2,7-dichlorodihydrofluorescein (DCF)
[52]. The removal of the acetate groups leaves the dye charged at physiological pH and
thus, unable to move freely out of the cell through the cell membrane. In this form, DCF
is weakly fluorescent; however, when it reacts with a ROS molecule it is oxidized and its
fluorescence efficiency increases significantly. Data from the manufacturer indicate the
excitation and emission wavelengths for maximum fluorescence of oxidized DCF
(oxDCF) are 488 nm and 529 nm, respectively. To determine if the oxDCF excitation
spectrum has a similar peak when the dye is within C6 cells I ran a spectrum using a 529
nm emission wavelength for excitation wavelengths ranging between 400 and 520 nm
(Figure 1). Cells were loaded with DCFDA for 15 min and then moved to the
fluorescence perfusion chamber as described in Methods. The sharp peak seen in Figure
1 at 469 nm is similar to the excitation peak for oxDCF in the literature [1]. The peak is
sitting on top of a broad non-specific endogenous fluorescence signal from the cells.

Oxidized DCF Emission Spectra
The emission spectrum in Figure 2 obtained from oxDCF in C6 cells looks similar
to the emission spectrum found in the literature [12]. The emission peaks for excitation
wavelengths of 475 nm, 480 nm, and 485 nm were 527, 525, and 524, respectively. The
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Figure 1: Excitation spectrum of oxidized DCF in C6 cells. C6 cells were loaded with
DCF for 15 min and then were transferred to a fluorescence cuvette for perfusion with 37
ºC isoosmotic PBS. The excitation spectrum over the range 400 nm to 520 nm was
obtained at an emission wavelength of 529 nm. The bandwidth of the excitation and
emission monochrometers (FWHM) was 8 nm.
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Figure 2: Emission spectra of oxidized DCF in C6 cells. C6 cells were loaded with DCF
for 15 min and then were transferred to a fluorescence cuvette for perfusion with 37 ºC
isoosmotic PBS. Fluorescence intensity between 500 nm and 600 nm was measured for
different excitation wavelengths as indicated. Scattered excitation light can be seen in
each spectrum from 500 nm to about 510 nm. The peak of the Raman water signal can
be seen between 560 nm and 585 nm (within box).
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excitation wavelength was first set at 475 nm (8 nm FWHM) and an emission spectrum
was measured from 500 nm to 600 nm. The resulting spectrum of oxDCF appeared to
rest on a baseline whose magnitude decreased with increasing wavelength (Figure 2).
Figure 2 shows a rapid drop off in arbitrary fluorescence units from 500 nm – 510 nm.
The fluorescence signal in this region is most likely from scattered light from the
excitation beam. Because the concentration of oxDCF is expected to be very low during
the initial period of fluorescence measurement I evaluated potential interference of
Raman fluorescence with the oxidized DCF fluorescence signal in the C6 cells. The
Raman signal for water is made up of several broad peaks centered at 563 nm for an
excitation of 470 nm and centered at 577 nm for an excitation of 480 nm [31]. Raman
fluorescence can be seen as broad peaks (Figure 2). When the excitation wavelength was
moved from 475 nm to 485 nm peak, the Raman spectrum moved from 570 nm to 580
nm on the long wave length tail of the oxDCF spectrum. Moving the excitation
wavelength decreased the interference of the Raman spectrum with the oxDCF signal.

ROS Production:
Initial studies of ROS production were measured with the cells perfused in
isoosmotic PBS (Figure 3). Emission spectra were taken every 5 min for 30 min while
perfusing the cells with isosmotic PBS as described in Methods. The baseline underlying
the oxDCF spectrum was assumed to be a straight line between 500 and 600 nm (solid
black line, Figure 3). To correct for this baseline when measuring oxDCF fluorescence, I
measured the emission at three wavelengths; 505 nm, 525 nm, and 600 nm. The peak
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Figure 3: Progressive oxidation of DCF in C6 cells. C6 cells were loaded with DCF for
15 min and then were transferred to a fluorescence cuvette for perfusion with 37 ºC
isoosmotic PBS. Emission spectra were acquired every 5 min using an excitation
wavelength of 475 nm. After 15 min 200 µM H2O2 was added to the isoosmotic PBS.
The baseline is a straight line drawn between the fluorescence intensity values measured
at 600 nm and 505 nm for the 0 min spectrum.
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height of the emission spectrum at 525 nm then was calculated relative to a linear
baseline calculated from the fluorescence emission signal measured at 505 and 600 nm.
The level of oxDCF within the cell increased in a time-dependent manner for 15
min, indicating a steady production of ROS. After 15 min I added 200 µM H2O2 to the
perfusing PBS and continued to acquire spectra for an additional 15 min. There was a 2fold increase in the quantity of oxDCF within 5 min of introducing H2O2 to the perfusing
PBS. After this initial burst of ROS production, the rate of increase in oxidized dye
leveled off suggesting that the H2O2 oxidized all the available unoxidized dye.
In initial studies, some of the cover slips showed unstable dye fluorescence during
solution changes. When solutions were changed there often was a sudden drop off in the
fluorescence intensity followed by an increase after 1-2 min in the new solution (Figure
4a). This drop in fluorescence intensity could be due to mechanical stress on the
membrane from the flow of PBS. In order to decrease the mechanical stress and help the
cells to stay on the coverslip better, I coated the coverslips with poly-lysine and
decreased the flow rate from 3 ml/min to 1 ml/min (data not shown). The drop in
fluorescence intensity did decrease with the slower perfusion rate, but the drop in
intensity was still consistently present. A possible cause for the drop in fluorescence was
efflux of the dye through hemi channels or other membrane channels in the cell
membrane that were activated during cell swelling. To block dye efflux through the
pathways I added 250 µM sulfinpyrazone or 100 µM carbenoxolone to all perfusing
solutions. Sulfinpyrazone had no effect on the apparent dye efflux (data not shown).
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Figure 4: DCF efflux is prevented with carbenoxolone. C6 cells were loaded with
DCFDA for 15 min and then were transferred to a fluorescence cuvette for perfusion with
37 ºC isoosmotic PBS. The fluorescence from oxDCF was measured while cells were
perfused with isoosmotic PBS for 10 min. Then the perfusate was changed to
hypoosmotic PBS for an additional 10 min A. DCF fluorescence in C6 cells during
perfusion with isoosmotic PBS, hypoosmotic PBS, and isoosmotic PBS containing 0.2
mM H2O2. B. DCF fluorescence in C6 cells during perfusion with isoosmotic and
hypoosmotic PBS containing 100 µM carbenoxolone.
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However, with the addition of carbenoxolone the sudden drops in intensity during
solution changes no longer present (Figure 4b).
In figure 4b there was a 60% increase in the rate of change in oxDCF
fluorescence that began when the solution was changed to hypoosmotic PBS (150 mOsm)
indicating an increase in ROS production rate. To normalize the data for differences in
dye loading or cell density, the fluorescence intensity for each data point was expressed
relative to the value measured in isoosmotic conditions immediately before hypoosmotic
or other experimental solutions were added. The mean of the normalized change in
oxDCF fluorescence for 18 trials of cells exposed to 150 mOsm hypoosmotic PBS is
presented in Figure 5. The immediate change in ROS production due to hypoosmotic
exposure was determined by comparing the slope obtained over one minute prior to the
change in hypoosmotic PBS to that obtained during the first minute after the change to
hypoosmotic conditions. The blue line represents the linear regression of the mean
normalized fluorescence intensities determined during the last minute of isoosmotic PBS
perfusion. The yellow line represents the linear regression of the mean normalized
fluorescence intensities determined during the first minute of hypoosmotic PBS
perfusion. The slope of the mean normalized fluorescence increased from 0.000382
normalized fluorescent units/sec during the last minute of isoosmotic exposure to
0.001143 normalized fluorescent units/sec when the solution was changed to
hypoosmotic PBS, an increase of almost 3-fold. On average, cells returned ROS
production to 0.000501 normalized fluorescent units/sec during the last min of
hypoosmotic PBS treatment.
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Figure 5: Hypoosmotic swelling causes a transient increase in ROS production. C6 cells
were loaded with DCFDA for 15 min and then were transferred to a fluorescence cuvette
for perfusion with 37 ºC isoosmotic PBS containing 100 µM carbenoxolone.
Fluorescence intensity determined every 10 s is expressed relative to the value measured
at the end of the isoosmotic exposure. The rate of ROS production was measured in
isoosmotic PBS for 10 min and then the perfusate was changed to hypoosmotic PBS plus
100 µM carbenoxolone for an additional 10 min. Values are the mean ± SEM of 18
independent measurements. The lines represent a linear regression of the data during 60
s prior to and immediately after the perfusate solution was changed to hypoosmotic PBS.
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Since the fluorescence cuvette holding the cells was 3 ml and the syringe moved
the solution into the cuvette at 1 ml/min, averaging ROS production over 1 min may
underestimate the initial change in ROS production due to hypoosmotic exposure.
However, a 3 minute time period was chosen to determine ROS production for
subsequent analysis to ensure the solution change in the cuvette was complete.
To examine the hypoosmotic dose-dependence of ROS production I measured the
increase in ROS production during exposure to either 200 mOsm PBS or 150 mOsm
PBS. For both 200 mOsm and 150 mOsm the rate of change in oxDCF fluorescence
significantly increased during the initial exposure to hypoosmotic PBS (initial
hypoosmotic) (Figure 6). The slope of the oxDCF fluorescence curve during the first 3
min of exposure to 200 mOsm hypoosmotic PBS was 141.6 + 18 % of the baseline rate in
isoosmotic PBS and for 150 mOsm hypoosmotic PBS the slope was 160.2 + 19.6 % of
the baseline rate in isoosmotic PBS. The slope for 200 mOsm and 150 mOsm
hypoosmotic exposure was very close, suggesting that there was not a dose-dependence
for hypoosmotic exposure. In both 200 mOsm and 150 mOsm PBS the rate of ROS
production decreased to baseline by the last 3 min of the 10 min exposure period to
hypoosmotic PBS.

Inhibitors of ROS Production
Antioxidants were added to see if they could block or reverse the effects of
hypoosmotic exposure on ROS production. I first examined the effects of these drugs
during isoosmotic exposure. One of two antioxidants, vitamin E (trolox C (150 µM)) and
vitamin C (ascorbate (400 µM)) were added to the perfusing isoosmotic PBS after the
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Figure 6: The magnitude of increased ROS production rate in hypoosmotic conditions.
C6 cells were loaded with DCFDA for 15 min and then were transferred to a fluorescence
cuvette and perfused with 37 ºC isoosmotic PBS containing 100 µM carbenoxolone.
Rate of ROS production was measured in isoosmotic PBS for 10 min and then perfusate
was changed to hypoosmotic PBS (200 mOsm or 150 mOsm) for an additional 10 min.
The rate of ROS production was determined during the first 3 min of perfusion with
hypoosmotic PBS (0-3 min) and during the last 3 min of the experiment (7-10 min).
These values are normalized to the ROS production rate measured in isoosmotic PBS
during the 3 min prior to the start of exposure to hypoosmotic PBS.
Values are the mean ± SEM of 11-18 independent measurements.
* Indicates values that are statistically different than 100%.
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150 mOsm

cells were in the fluorescence cuvette for 10 min to determine the effects of the
antioxidants in isotonic conditions. Trolox C significantly increased ROS production in
isoosmotic PBS by 35 + 12 % (Table 1) while ascorbate had no effect on ROS
production.
When trolox C, but not ascorbate, was present in the PBS solutions there was no
significant increase in ROS during hypoosmotic treatment (Figure 7). With ascorbate
there was a 55.5 + 14 % increase in ROS production during the first 3 min of
hypoosmotic exposure, which is similar to the effect in control hypoosmotic conditions
(without drug). ROS production then decreased, similar to its response in the absence of
drug, back to the baseline value. Trolox C, on the other hand, inhibited the initial
increase in production of ROS during hypoosmotic exposure. By the end of the
experiments with trolox C there was a significant decrease in the rate of ROS production
to 51.3 + 14.8 % below baseline.
The two major pathways of ROS production are NADPH oxidase and the electron
transport chain (ETC) in the mitochondria. In order to determine if ROS production
during hypoosmotic conditions was due to either of these pathways, they were blocked
using the pharmacological agents, diphenyleniodonium (DPI), a NADPH oxidase
blocker, or rotenone plus oligomycin to block the ETC [2, 84].
In isoosmotic conditions DPI did not alter ROS production compared with
baseline (Table 1). However, in hypoosmotic conditions ROS production increased to
162.7 + 33.3 % of control levels in the presence of DPI during the first 3 min of
exposure. ROS production then decreased significantly below the control levels after 10
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Table 1: Antioxidant effects on ROS production in isoosmotic conditions

Drug

ROS Production Rate
(% of Control)

Control

100%

150 µM Trolox

135 ± 12 % *

400 µM Ascorbate

98 ± 18%

10 µM DPI

105 ± 36%

C6 cells were perfused with isoosmotic PBS prior to antioxidant exposure. Rates of ROS
production were measured during the first 3 min of antioxidant exposure and are
normalized to the ROS production rate measured during the 3 min prior to the start of
antioxidant exposure (Control).
Values are the mean of 6-9 independent measurements.
* indicates values significantly different from 100% (p<0.05).
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Figure 7: ROS production during hypoosmotic treatment in the presence of antioxidants.
Rates of ROS production were measured while cells were perfused with isoosmotic PBS
for 10 min and then changed to perfusion with hypoosmotic PBS for an additional 10
min. All solutions contained 100 µM carbenoxolone. For experimental studies, the
antioxidants, trolox C (150 µM) or ascorbate (400 µM), were added during the last 5 min
of isoosmotic exposure and throughout the hypoosmotic exposure period. The rate of
ROS production was calculated during the 3 min immediately after the start of
hypoosmotic treatment (0-3 min) and during the last 3 min of hypoosmotic treatment (710 min). These values are expressed relative to the rate of ROS production measured in
isoosmotic PBS during the 3 min just prior to the start of hypoosmotic exposure
(Control). Values shown are the mean ± SEM of 7-18 independent measurements.
* indicates significant differences from the rate of ROS production in isoosmotic PBS
(p<0.05).
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min. In the presence of rotenone plus oligomycin there was a significant increase in ROS
production throughout the period of hypoosmotic exposure. The initial increase was 83.7
+ 27.9 %, above control levels, a value which was not significantly different from that
measured in cultures exposed to hypoosmotic PBS without drug. But, there was a further
increase to 102.6 + 36.7 % above the baseline rate during the last 3 min of the 10 min
exposure. This was significantly higher than the rate of ROS production measured in
control conditions (Figure 8).

Activation of ROS production by ATP:
Because ATP is released from swollen cells and has been shown to activate
volume regulation in many cell types, I examined whether elevated extracellular ATP
signaled an increase in ROS production in the C6 cells. As described in methods C6 cells
received a series of solution changes that mimicked the protocol used when performing
fluorescent measurements of ROS production. In the absence of carbenoxolone in PBS,
C6 cells showed a significant decrease in ATP efflux in hypoosmotic conditions
compared with the efflux measured from cells in isoosmotic PBS (Figure 9). In the
presence of carbenoxolone, there was no change in ATP efflux in hypoosmotic
conditions compared to the efflux measured in isoosmotic conditions. The assay used to
measure ATP efflux in this experiment is relatively sensitive. Cells contain about 3-5
mM of ATP, and the C6 cells effluxed about 0.35 mM of ATP when exposed to PBS in
the presence of carbenoxolone. Thus, I was able to measure a efflux of about 10% of the
ATP within the cells during the 10 min exposure in C6 cells when exposing them to PBS.
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Figure 8: Swelling-induced ROS production during hypoosmotic treatment in the
presence of NADPH oxidase or mitochondrial electron transport inhibitors. Rates of
ROS production were measured while cells were perfused with isoosmotic PBS for 10
min followed by perfusion with hypoosmotic PBS for an additional 10 min. For
experimental cultures, the drug treatments, DPI (10 µM) or rotenone (5 µM) plus
oligomycin (10 µM), were added for 5 min prior to and throughout the exposure to
hypoosmotic PBS. The rate of ROS production was calculated during the 3 min
immediately after the start of hypoosmotic treatment (0-3 min) and during the last 3 min
of hypoosmotic treatment (7-10 min). These values are expressed relative to the rate of
ROS production measured during the 3 min just prior to the start of hypoosmotic
exposure. Values shown are the mean ± SEM of 7-18 independent measurements.
* indicates significant difference from the rate in isoosmotic PBS, p<0.05.
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Rotenone/Oligomycin

Figure 9: ATP release from C6 cells in isoosmotic and hypoosmotic conditions. Total
ATP released from C6 cells was measured during a 10 min exposure to isoosmotic or
hypoosmotic PBS. Some cultures had 100 µM carbenoxolone present during the
exposure period. For cells exposed to carbenoxolone in hypoosmotic PBS, this drug also
was added to the isoosmotic PBS 5 min prior to introduction of hypoosmotic PBS.
Values shown are the mean ± SEM of 7-18 independent measurements.
* indicates significant difference from the rate in isoosmotic PBS, p<0.05.
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Hypoosmotic

Table 2: ATP does not activate ROS production in isoosmotic PBS

Time

ROS Production Rate
(% of Isoosmotic)

0-3 min

1.06 + 0.089 %

7-10 min

0.87 + 0.077 %

Cells were exposed to isoosmotic PBS for 10 min and then changed to isoosmotic PBS
plus ATP for an additional 10 min. The rate of ROS production was calculated during
the 3 min immediately after the start of isoosmotic treatment plus ATP (0-3 min) and
during the last 3 min of isoosmotic treatment plus ATP (7-10 min). These values are
expressed relative to the rate of ROS production measured during the 3 min just prior to
the start of ATP exposure.
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To test if ATP directly activated ROS production, I added 100 µM ATP to the
solution perfusing the cells in isoosmotic PBS (Table 2). This concentration of ATP is in
the range that activates channels associated with cell volume regulation (10-100 µM)
[98]. ROS production did not increase when ATP was added to cells in isoosmotic PBS.
Furthermore, when I added this concentration of ATP to cells perfused with hypoosmotic
PBS, ROS production increased similarly to that observed for cells perfused with
hypoosmotic PBS in the absence of ATP (Figure 10). However, at the end of the
experiment, cells in hypoosmotic PBS plus ATP still had a rate of ROS production that
was significantly greater than the rate measured in isoosmotic PBS.

Cytotoxicity:
Apoptotic and necrotic cell death was evaluated following hypoosmotic exposure
using annexin V and trypan blue staining and release of lactate dehydrogenase. Because
trypan blue only stains cells with permeable membranes, staining with this dye was used
to identify necrotic cell death (Figure 11, Table 3). When the cells were in isoosmotic
PBS plus trolox C, ascorbate, or DPI there was a very small but significant increase in
cell death compared to the amount determined in cells without drug exposure. In
hypoosmotic conditions, a significantly greater number of cells were trypan blue-positive
compared to the number in isoosmotic conditions. There also was a significant increase
in cell death when the cells were exposed to trolox C and ascorbate. This increase was
not apparent when the cells were exposed to DPI, though it was close to statistical
significance. After 24 hr in H2O2 nearly 9 % of the cells were trypan blue-positive. In
order to make sure that the cytotoxic cells were not coming off the dish, the cells were
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Figure 10: ATP activates ROS production in hypoosmotic PBS. C6 cells were exposed
to ATP (100 µM) while they were perfused with hypoosmotic PBS. The normalized rate
of ROS production was calculated during the first 3 min of hypoosmotic exposure (0-3
min) and during the last 3 min of the experiment (7-10 min). Values shown are the mean
± SEM of 8-10 independent measurements.
* indicates significant difference from the rate in isoosmotic PBS, p<0.05.
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Figure 11: Hypoosmotic-induced cell death. After treatment for 1 hr with isoosmotic
PBS, hypoosmotic PBS, or H2O2, cells were returned to serum-free growth medium.
Twenty-four hours later cells were stained with trypan blue to measure cell death and
DAPI to count the total cell number. The bar indicates 100 µm.
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Table 3: Hypoosmotic-induced cell death.

PBS

Isoosmotic

Hypoosmotic

Isoosmotic

Treatment

Percent Trypan BluePositive Cells

None

0.11 + 0.03 %

Trolox

0.39 + 0.05 % *

Ascorbate

0.35 + 0.07 % *

DPI

0.37 + 0.06 % *

None

0.24 + 0.05 % *

Trolox

0.40 + 0.05 % *

Ascorbate

0.28 + 0.04 % *

DPI
H2O2

0.22+ 0.08 %
8.5 + 1.6 % *

Cells were exposed to isoosmotic PBS or hypoosmotic PBS for 1 hr and then returned to
serum-free growth medium for 24 hours. Data represents the percentage of trypan bluepositive cells. Some cultures had 500 µM H2O2 added to the growth medium for 24
hours.
* indicates significant difference from the percent of trypan blue positive cells in
isoosmotic PBS, p<0.05.
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stained with DAPI to count the cell nuclei. Counting the cells revealed that each
experimental group averaged about 500 cells per microscopic field. The only exception
was H2O2, where there was only about 300 cells per microscopic field. The number of
cells undergoing apoptosis was evaluated by staining the cells with annexin V, to mark
apoptotic calls and DAPI, to mark all cell nuclei (Figure 12). Annexin V is not always an
effective dye to use on monolayer cells like C6 cells because there is usually high
background fluorescence. The C6 cells did not have this high background in isoosmotic
or hypoosmotic PBS and thus annexin V could be used to measure apoptosis (Figure 12).
The numbers of DAPI-positive and annexin V-positive cells for various experimental
conditions are shown in Table 4. Cells exposed to isoosmotic PBS or hypoosmotic PBS
(200 mOsm and 150 mOsm) did not show a significant increase in the cells labeled by
annexin V compared with cells maintained in growth medium. Exposure of cells to
hydrogen peroxide was used as a positive control. I found that there was a significant
increase in apoptotic cell death when the cells were exposed to 500 µM H2O2 for 24 hrs.
Cytotoxicity was determined by measuring LDH release from cells. LDH release
in each experimental condition was expressed as a percentage of LDH released from cells
exposed to isoosmotic conditions measured on the same day. A significant increase in
LDH release occurred when cells were exposed to either ascorbate or DPI in isoosmotic
PBS (Table 5). Exposure of cells to 150 mOsm hypoosmotic PBS resulted in a 13.5 +
6.3 % increase in LDH release over that measured from cells exposed to isoosmotic PBS
(Figure 13). The antioxidants did not alter the effect of hypoosmotic PBS on LDH
release.

78

Figure 12: Hypoosmotic conditions do not cause apoptosis. Cells were exposed to
isoosmotic PBS or hypoosmotic PBS for 1 hr and then returned to serum-free growth
medium for 24 hours. Some cultures had 500 µM H2O2 added to the growth medium for
24 hours. Cultures were stained with annexin V and DAPI as described in Methods. The
bar indicates 100 µm.
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Annexin V

Table 4: Percentage of annexin V-positive cells does not significantly change following
hypoosmotic exposure.

Treatment

Percent Annexin V-positive cells

Control

0.50 ± 0.10 %

Isoosmotic

0.44 ± 0.16 %

Hypoosmotic

0.74 ± 0.14%

H202

50.6 + 12.5% *

Cells were exposed to isoosmotic PBS or hypoosmotic PBS for 1 hr and then returned to
serum-free growth medium for 24 hr. Some cultures had 500 µM H2O2 added to the
growth medium for 24 hr. Other cultures were not exposed to any experimental
condition (control). Cultures were stained with annexin V and DAPI as described in
Methods. Values are the mean percentage of annexin V-positive cells from independent
measurements.
* indicates values that are significantly different from the percentage of annexin Vpositive cells in control cultures.
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Table 5: C6 cell cytotoxicity in response to antioxidant treatments.

Treatment

LDH Release
(Percent of Control)

Control

100%

Trolox C

103.7 + 4 %

Ascorbate

125.3 + 13.2% *

DPI

126.2 + 21.2%*

Cells were exposed to isoosmotic PBS for 1 hr and then returned to serum-free growth
medium for 24 hours. Some PBS solutions also contained trolox C (150 µM), ascorbate
(400 µM), or DPI (10 µM). LDH content in the growth medium was determined as a
fraction of the total LDH in cells plus medium. The fraction of LDH released from cells
treated with drug is expressed as a percentage of the fraction of LDH release determined
from dishes treated with isoosmotic PBS on the same day (Control). Data are the mean +
SEM for 5-10 independent experiments.
* indicates mean values which are significantly different from the fraction of LDH
release measured for cells treated with isoosmotic PBS without drug, p<0.05.
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Figure 13: Hypoosmotic swelling causes cytotoxicity. Cells were exposed to
hypoosmotic PBS (150 mOsm) for 1 hr and then returned to serum-free growth medium
for 24 hours. Some PBS solutions also contained trolox C (150 µM), ascorbate (400
µM), or DPI (10 µM). The fraction of LDH released from cells treated with hypoosmotic
PBS with or without added drug is expressed as a percentage of the fraction of LDH
release determined from dishes treated with isoosmotic PBS without drug on the same
day (Control). Data are the mean SEM for 5-10 independent experiments.

* indicates mean values which are significantly different from the fraction of LDH
release measured for control cells, p<0.05.
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V. Discussion
The results of these studies show that when exposed to hypoosmotic conditions
C6 cells increase their rate of ROS production. The hypoosmotic induced increase in
ROS production can not be inhibited by blocking NADPH oxidase with DPI or inhibiting
the ETC with rotenone plus oligomycin. Antioxidants also were unable to block the
increased ROS production during hypoosmotic exposure. When ATP was added to the
extracellular solution, C6 cells did not increase their ROS production. Also, there was no
increase in ATP efflux under experimental conditions when cells were exposed to
hypoosmotic PBS. There was an increase in cytotoxicity when the cells were exposed to
hypoosmotic conditions, but this increase was very minimal.

Optimal conditions for measuring oxDCF fluorescence in C6 cells
To determine the characteristics of oxidized DCF (oxDCF) when it is present in
C6 cells, I examined excitation and emission spectra of the dye after loading the cells
using the diacetate derivative of DCF. Oxidized DCF in solution has a sharp emission
peak at 529 nm when excited at 488 nm [12]. The emission spectrum measured for the
C6 cells (Figure 3) is very similar to the emission spectrum published by manufacturer
(InVitrogen) [1]. Thus, the fluorescence characteristics for oxDCF in the cell are similar
to those determined for the dye in solution.
When the oxDCF signal is low, the water Raman signal and scattered light from
the excitation beam may interfere with the fluorescence signal. The maximum of the
emission spectrum for oxDCF is 529 nm, and as seen in Figure 2, the Raman spectrum
obtained with a 470 nm excitation may interfere with the oxDCF spectrum. Using an
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excitation wavelength of 475 nm decreased interference of the Raman signal by moving
it farther away from the oxDCF spectrum. Moving the excitation wavelength to 475 nm
also minimally increased the amount of scattered light from the excitation beam that was
detected when the emission light was gathered at 525 nm. Therefore, an optimum was
found empirically at 475 nm where the Raman emission is moved as far as possible to
longer wavelengths consistent with only a small degree of scattered excitation light
appearing in the emission beam.
With an excitation wavelength of 475 nm and emission wavelength of 525 nm,
the emission spectrum appeared to contain a sloping background that was possibly due to
scattered light from the excitation beam or autofluorescence from the cells. This
background signal decreased with increasing wavelength and appeared independent of
dye oxidation. At the beginning of the experiment, when the dye levels were low, this
background constituted a significant portion of the total signal, and thus, could mask
changes in oxidized dye content of the cells. The intensity of the background slope at the
maximum dye emission wavelength was estimated by linear regression of fluorescence
intensities measured at wavelengths above and below the oxidized DCF emission
maximum. The calculated background was then subtracted from the emission peak at
525 nm (Figure 3).
Initial studies suggested cells were losing significant quantities of oxidized dye
when solutions were changed. Many cell lines have plasma membrane connexin
hemichannels which may be permeable to small molecules such as native and oxidized
DCF. These pathways may be activated by cell swelling [136]. Thus, to decrease this
loss of dye when changing solutions, an inhibitor of connexin hemichannels,
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carbenoxolone, was added to all solutions perfusing the C6 cells. With carbenoxolone
present in the perfusion solutions, I did not observe a sudden drop in fluorescence at the
time of solution changes as seen previously and the variability of the fluorescence signal
during constant perfusion conditions was diminished. C6 cells grown in serumcontaining medium do not express a high concentration of connexins [33] typical of
mature astrocytes. However, transferring the cells to serum-free medium as was done in
these studies, morphologically changes the cells to be more astrocytic in appearance [14].
This differentiation of these cells may increase the amount of connexin expressions since
C6 cells treated with serum-free medium plus dimethyl sulfoxide, increase the amount of
connexin expression [90]. It is unclear if carbenoxolone is inhibiting oxDCF dye efflux
by blocking hemichannels or by some other mechanism.

Hypoosmotic swelling causes increased ROS production
C6 cells produce ROS at a constant rate in isoosmotic conditions. There is a
transient increase in the rate of ROS production when cells are exposed to hypoosmotic
conditions. The increase in ROS production during hypoosmotic conditions can not be
blocked by the antioxidants trolox C or ascorbate, nor can it be inhibited by blocking the
NADPH oxidase complex with DPI, or the ETC with rotenone plus oligomycin. It has
been shown that other cells increase ROS production during swelling [91, 156, 163].
ROS may be acting as intracellular signals to activate RVD, opening channels for ion
efflux and cell shrinkage [156, 163]. C6 cells, like other astrocytic cell lines use a
conductive pathway to efflux K+ and Cl during RVD [48, 127, 133]. The way in which
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the conductive pathway is activated is still unclear, but specific K+ and Cl channels on
the membrane must be activated for RVD to occur in C6 cells.
ROS act as intracellular signals in many processes within the cell by acting on
cysteine residues [129]. ROS oxidize the sulfur groups within the cysteine residues
forming an intra or inter-molecular bond via the resulting disulfide moiety [37]. For
example, when H2O2 reacts with the amino terminal of protein kinase C (PKC) there is a
conformational change that occurs allowing PKC to be phosphorylated and thus
activating the pathway. Contrarily, when ROS reacts with the carboxyl terminal of PKC
it is inactivated [129]. PKC has been shown to play a role in volume regulation in rat
astrocytes [20]. Inactivation of PKC, which can be accomplished by ROS, induces cell
shrinkage [20, 129]. Thus the increased ROS production during hypoosmotic swelling
could be used to inactivate PKC in order to reduce cell volume.
The addition of antioxidants during hypoosmotic exposure did not protect the
cells from the increase in ROS production. In order to explore the mechanism of ROS
production in hypoosmotic conditions, I added two different antioxidants. One was lipid
soluble, trolox C, and the other was water soluble, ascorbate. Trolox C actually caused
an increase in ROS production during isoosmotic conditions. While this may indicate an
increase in cellular ROS production, trolox C also may be shuttling radicals to the DCF.
Antioxidants work within the cell by creating stable free radicals that then react with the
cellular free radicals to terminate the free radical reactions [158]. A possible reason for
the increase in oxDCF when trolox C was added to the cell is that the free radicals
formed by the antioxidant were directly oxidizing DCF. Therefore, while the results
suggested an increase in ROS production, trolox C may be directly oxidizing the dye thus
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mimicking increased ROS production. Another possible reason for the increase in
oxDCF when trolox C was added in isoosmotic conditions is trolox C is acting as a prooxidant. Many antioxidants act as pro-oxidants when they are present in high
concentrations. In isoosmotic conditions the antioxodiant (trolox C) to ROS ratio was
very high and therefore trolox C could have been acting like a pro-oxidant.
There did not appear to be a significant increase in ROS production during the
initial hypoosmotic exposure above the increase that was already present from trolox C in
isoosmotic PBS. The trolox C is shuttling radicals to oxidize DCF or pro-oxidant effect
was happening at a maximal rate in isoosmotic conditions, thus there was no change with
the addition of hypoosmotic PBS. Therefore, when the cells are changed to hypoosmotic
solutions there is no further increase possible for DCF dye oxidation. But there was a
decrease in the ROS production with trolox C in hypoosmotic PBS at the end of the
experiment compared to trolox C in isoosmotic PBS. This would suggest that as the ROS
level increased in the cell, the ratio of trolox C to ROS decreased and trolox C was no
long acting as a pro-oxidant in the cells.
The addition of ascorbate did not cause an increase in the rate of ROS
production in isoosmotic conditions or hypoosmotic conditions. Ascorbate, like trolox C,
can act as a pro-oxidant or antioxidant depending on the concentration within the cell.
Ascorbate can react with transition metals and form hydroxyl radicals and lipid alkoxyl
radicals [32]. Pro-oxidant effects of ascorbate seem to be due to an increase in
extracellular ascorbate, not intracellular, and cause an increase in H2O2 production [34].
H2O2 is permeable to the membrane and thus could enter the cell and oxidize DCF.
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Therefore, ascorbate concentrations used in this study did not seem to have a pro-oxidant
effect on C6 cells.
In hypoosmotic conditions, there was a significant increase in ROS production
that decreased to baseline within 10 min of hypoosmotic exposure. The results found
with ascorbate mimicked the results during hypoosmotic PBS, alone. Ascorbate did not
act as an antioxidant in hypoosmotic conditions to decrease the amount of free radicals
within the cell. The lack of effect with ascorbate could be due its inability to cross the
membrane fast enough to have a protective effect on the cells during this short period of
exposure.
The intracellular concentrations of ascorbate are tightly controlled by the cell
[34]. Because of the size of ascorbate, it is unable to permeate the plasma membrane
[167]. The normal uptake of ascorbate is highly Na+ dependent using a 2Na+:1 ascorbate
co-transporter [39, 150]. In hypoosmotic conditions, astrocytes also use a volumesensitive organic anion channel to efflux ascorbate [39]. Many studies pre-treat the cells
with ascorbate in order to allow the cell to actively transport ascorbate across the cell
membrane. As cells were not pre-treated with ascorbate in this study, there might not
have been adequate time for the ascorbate to enter the cell. If the ascorbate was unable to
enter the cell this would explain the lack of antioxidant effect in hypoosmotic conditions.
Some ROS producers, such as NADPH oxidase, produce the ROS extracellularly.
NADPH oxidase produces superoxide extracellularly where it is converted to H2O2 and
then crosses the membrane to act as an intracellular signal. The lack of effect of
extracellular ascorbate seems to indicate that the increased ROS production during
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hypoosmotic swelling was due to an increase in intracellular ROS production, not
extracellular ROS production.

Site of hypoosmotic induced increase in ROS production
DCF is oxidized to a fluorescent compound when it interacts with any one of
several different ROS molecules [94]. To determine the ROS species that was being
produced during hypoosmotic exposure and their source, blockers of ROS pathways were
used.
The main ROS producers are the NADPH oxidase complex, mitochondria,
xanthine oxidase and nitric oxide synthase. In order to determine if ROS produced
during hypoosmotic swelling in C6 cells was due to NADPH oxidase complex, DPI was
used to inhibit NADPH oxidase. In astrocytes, activation of NADPH oxidase has been
shown to increase ROS production [2, 135]. Astrocytes exposed to hypoosmotic
conditions increase serine phosphorylation of p47phox [135] that then causes p47 phox to
undergo a conformational change that opens up a binding site for interaction with the
membrane bound component, p22 phox. When p47 phox and p22 phox come together, they
bring the other components with them to causes activation of NADPH oxidase and,
therefore, production of ROS [57]. DPI acts by irreversibly inhibiting flavoproteins such
as the NADPH:O2 oxi-reductase [15, 155]. In my studies, DPI added to cells exposed to
hypoosmotic PBS did not inhibit the initial burst of ROS production, but significantly
decreased the amount of ROS produced after 10 min of hypoosmotic treatment. These
results suggest that NADPH oxidase is not responsible for the initial increase in ROS
when cells are exposed to hypoosmotic conditions. However, the further decrease in
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ROS production at the end of the 10 min observation period suggests that ROS
production in hypoosmotic conditions is biphasic. The continual production of ROS
during hyposmotic exposure could be dependent on an activated NADPH oxidase
complex.
Another possible site for ROS production during cell swelling is the ETC of the
mitochondria. Rotenone plus oligomycin was used to inhibit the ETC for ROS
production in hypoosmotic conditions. Rotenone is added to block normal electron
transport and thus, collapses the mitochondrial membrane potential. Oligomycin is used
to inhibit the reverse movement of electrons driven by reversal of the ATP synthase [28].
Others have shown that oligomycin plus rotenone could block complex I and V,
respectively, of the ETC and significantly decrease ROS production [30].
Since oligomycin plus rotenone added to the PBS did not decrease the initial ROS
production to swollen C6 cells, I conclude the ETC is not responsible for this increased
ROS production. However, when the ETC was blocked, ROS production did not return
to baseline at the end of the experiment, instead it continued to increase, at the increased
rate, throughout the experiment.
The increase in ROS production during the initial phase of hypoosmotic exposure
was not due to NADPH oxidase nor the ETC. These are two of the primary producers of
ROS within the cell, but they are not the only ones. Other potential sources of ROS
during hypoosmotic swelling are XO and NO synthase. Activation of XO causes an
increase in both O۠2 and H2O2 [70] which can increase the fluorescence of DCF [94].
Phosphorylation of XO for activation is mediated in part by p38 kinase [81]. This kinase
is activated during hyperosmotic stress, and therefore, was not a high priority of

92

investigation for this study [81]. Nitric oxide synthase is another ROS producer that
could be activated during hypoosmotic stress. NO synthase has been shown to be
activated in astrocytes during an immune response [61]. NO acts as an intracellular
second messenger [58] which could be used in the cells during hypoosmotic swelling to
regulate their volume. There is evidence that NO derivatives are able to activate the KCl co-transporter [4, 5]. This would indicate that NO possibly plays a role in RVD in
some cell lines. C6 cells do not use the K-Cl co-transporter for RVD, and it is still
unclear if NO activates the KCl efflux via the conductive pathway, which is the pathway
that C6 cells use.

ATP- activated ROS production
Hypoosmotic swelling-induced ATP release is known to occur in many different
cell types [74]. Extracellular ATP is used to induce various biological responses via the
activation of purinergic receptors through autocrine and paracrine mechanisms. The ATP
released into the extracellular space during hypoosmotic swelling is known to stimulate
processes that regulate cell volume [27, 71, 74, 98, 138]. ATP released from primary
astrocytes undergoing hypoosmotic stress is necessary and sufficient to activate volumeregulated anion channels (VRAC) [86, 113, 114] Li and Olson also found that
extracellular ATP activated membrane chloride conductances in astroglial cells and
neurons [98]. The presence of extracellular ATP can potentiate VRAC activity in
swollen cells which can result in volume regulation by conducting taurine and potentially
other small organic molecules [98]. The organic and inorganic osmolytes that are lost
from the cell via VRAC result in volume regulation [113].
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Volume-regulated anion channels are an important part of volume regulation in
several cell types. Two molecules that play a role in the activation of VRAC are ATP
and ROS, though it is unclear how these two molecules activate VRAC [114, 163].
Extracellular ATP activates P2Y receptors causing the release of Ca2+ from intracellular
stores via activation of a phospholipase C (PLC) signaling pathway [114]. The
intracellular Ca2+ activates PKC and calmodulin as parallel pathways. Calmodulin
activates Ca2+/calmodulin-dependent kinase II which along with PKC regulates VRAC
activity [114]. Other studies have shown that H2O2 produced via increased NADPH
oxidase activity is necessary to activate volume sensitive Cl channels [114, 163].
However, the relationship between ATP and ROS pathways for activation of VRAC
channels is not clear.
ATP efflux is common among many mammalian cells and is induced by stimuli
such as changes in cell volume, mechanical stress, or cAMP [74, 113]. When most
mammalian cells are swollen under hypoosmotic conditions they release ATP from
within, and thus operate as an autocrine activator of volume regulated channels such as
VRAC [113]. Contrarily, in my experiments the efflux of ATP from C6 cells was not
increased under experimental conditions when carbenoxolone was added during
hypoosmotic exposure. This suggests that ATP is not likely to play an important role in
volume regulation of C6 cells.
ATP did not increase ROS production in isoosmotic conditions and thus, I
conclude increased extracellular ATP alone is not sufficient to activate ROS production.
The lower concentration of ATP, such as 100 µM that was used in this experiment, is
able to activate P2Y-receptors which participate in volume regulation in hypoosmotic-
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medium [86]. Millimolar concentrations of ATP are needed to activate the P2X7 receptor
which is responsible for ATP-induced cell swelling and necrotic cell death [79]. Most
cells have ecto-ATPases in the extracellular space that hydrolyzes extracellular ATP to
AMP. In C6 cells, the primary ecto-enzyme is ecto-nucleotide pyrophosphatase [38, 79].
When ATP is added to the extracellular space of C6 cells, some ATP is hydrolyzed to
AMP and PPi. When the extracellular concentration of ATP is from 1-10 µM the ectoenzymes of C6 cells are about 75% effective at hydrolyzing ATP to AMP. At higher
concentrations such as 100 µM the ecto-enzyme is only about 50% effective [38].
Therefore, it is possible that about 50% of the ATP that was added to the cells was
hydrolyzed to AMP and PPi before it reached the cell membrane. In hypoosmotic
conditions with ATP there was a significant increase in ROS production similar to that
observed in the absence of exogenous ATP. However, in hypoosmotic conditions plus
ATP the increase in ROS production continued throughout the experiment, remaining
elevated for as long as 10 min. This suggests that there is a synergistic interaction
between swelling and ATP to enhance ROS production similar to Kimelberg’s and
Mogin’s data on amino acid release and Li et al.’s data on anion channels [86, 98, 114].
Mogin and Kimelberg found that ATP release is not necessary or sufficient to activate
VRAC, but ATP adjusts the already active VRAC [114]. Similar to this study, Li et al.
observed that ATP enhanced the activity of amino acid efflux through anion channels
during hypoosmotic swelling [98]. The current data suggests that ATP is not sufficient to
activate ROS production, but that ATP does enhance ROS production. ATP would
provide a positive feed-forward loop that increases ROS production explaining the
continual increase in ROS production at the end of the 10 min exposure.
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Cytotoxicity:
Cell death can occur in two different ways, necrosis and apoptosis. ROS can play
a part in inducing both forms of cell death. In C6 cells, apoptosis is mediated by p53 and
ERK. Activation of these pathways can be initiated by H2O2 [24, 35, 87, 96]. ROS can
induce necrosis when there is an uncontrollable increase in ROS. In these situations,
ROS are no longer acting as second messengers within the cell; instead, they are
oxidizing DNA, proteins, and lipids. The oxidation of DNA, proteins, and lipids causes
irreversible cellular damage [106, 130].
Using 3 methods to measure cell death I found that there was a slight increase in
cell death via necrosis due to hypoosmotic exposure. Trypan blue staining revealed there
was a significant increase in necrotic cell death when the cells were exposed to
hypoosmotic PBS compared to isoosmotic PBS. There was a 2-fold increase in cell death
when the cells were exposed to hypoosmotic conditions, but this increase in cell death
was only about 0.24% of the total cell number.
The antioxidants trolox C and ascorbate as well as the NADPH oxidase inhibitor
DPI increased the amount of cell death measured in cells exposed to in isoosmotic PBS.
While there was a 3-fold increase in cell death when the cells were exposed to trolox C,
ascorbate, and DPI, this increase was very small; from 0.11% in isoosmotic cells to
0.35% – 0.39% in treated cells.
The increase in cell death observed in C6 cells exposed to hypoosmotic conditions
could not be prevented with the antioxidants trolox C or ascorbate. Blocking NADPH
oxidase with DPI also did not protect the cells. While it is possible that dead cells came
off the dish and therefore were not stained with trypan blue, the DAPI staining seemed to
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suggest otherwise. Each of the experimental groups had the same density of cells per
microscopic field. In contrast, cells exposed to H2O2 had a significantly lower count of
cells per microscopic field.
I determined if cell death increased due to apoptosis in hypoosmotic conditions
using annexin V staining. There was no significant increase in the cell death via
apoptosis when the cells were exposed to hypoosmotic or isoosmotic medium. Hydrogen
peroxide, used as a positive control, gave a significant increase in cell death.
To determine if necrosis occurred when the cells were exposed to hypoosmotic
conditions we measured the LDH release of the cells. When the cells were exposed to
hypoosmotic PBS there was a significant increase in cell death, but the increase in cell
death was only 13.5 + 6.5 % above control levels. This suggests that hypoosmotic
treatment did have an effect on the cells, but it did not cause wide spread cell death
throughout the culture. When cells were exposed to ascorbate or DPI in isoosmotic PBS
there was a significant increase in cell death. In isoosmotic conditions, trolox C did not
induce an increase in cell death.
The cell death measured in the current experiment was not due to an increase in
ROS production. When cells that were treated with ascorbate were exposed to
hypoosmotic solutions they did not increase their ROS production, never-the-less there
was a significant increase in cell death. If the cell death was due to the increased ROS
production, then cells that did not increase in ROS production should not have increased
in cell death. Astrocytes, like many other cell types, have endogenous antioxidants that
may protect them from damage caused by the increase in ROS production that occurs
when the cells are swollen in hypoosmotic conditions [145]. It is probable that the
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antioxidants within the C6 cells were capable of preventing cell death due to the
increased ROS production. Since the increase in cell death did not correlate with the
ROS production, the cell death observed in these experiments must be due to another
mechanism within the cell.
The increase in LDH measured in hypoosmotic treated cells was quantified
different from cell death determined with trypan blue staining. There was a statistically
significant increase in cell death with both LDH released and trypan blue staining, but the
percent of cell death with trypan blue was much lower than the 12% increase measured
for LDH release (only about a 0.25% increase in hypoosmotic exposure over that of
control cells). The much lower percentage of cell death in response to hypoosmotic
exposure measured with the trypan blue staining could be because the LDH is a more
sensitive indicator of cell injury than trypan blue. However, though the results are not
quantatively comparable, the trends are similar. There was a small increase in necrotic
cell death with hypoosmotic exposure, but this death was not due to an increase in ROS
production.
The cell death observed in this study was very low and therefore could be
accounted for by daily cellular turnover. Normal turnover for most cell lines in a day is
about 10%; therefore, the cell death found in this experiment was very likely due to cell
turnover. The increase in cell death, though it is statistically different is not
physiologically significant.
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VI. Conclusion
The data presented here suggest that C6 cells exposed to hypoosmotic conditions
increase ROS production. This ROS production is not directly activated by extracellular
ATP release from the cells, but exogenously applied ATP further increased ROS
production. Hypoosmotic conditions slightly increase cytotoxicity of C6 cells, but most
cells seem to be capable of surviving the oxidative stress, possibly due to endogenous
antioxidants that react with the increased oxygen free radicals.
Cells are exposed to hypoosmotic conditions increase ROS production. This
increase is not blocked by either of the antioxidants, trolox C or ascorbate. Since trolox
C cause an increase in ROS production in isoosmotic conditions it may be acting as a
pro-oxidant within C6 cells. These results also suggest the increased ROS production
due to hypoosmotic conditions is biphasic. NADPH oxidase blockers could not inhibit
the initial burst of ROS production, but did decrease ROS production by the end of the
experiment to below the baseline levels. This may be because the initial burst in ROS is
due to another pathway, but prolonged ROS production in hypoosmotic conditions is due
to NADPH oxidase.
Unlike many other cell lines, C6 cells do not lose ATP when exposed to
hypoosmotic conditions. There was a 10% loss of ATP when the cells were exposed to
PBS, but this did not change with hypoosmotic exposure. Thus pathways other than the
purinergic receptors must be used to activate the efflux of ions and organic osmolytes
responsible for RVD.
Though most of the experimental conditions did induce a significant, but small,
amount of cell death, this did not seem to be caused by the increase in ROS production.
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These studies suggest that C6 cells are capable of surviving in the midst of extreme
osmotic changes without causing significant cytotoxic damage. This study did not
specifically look at the change in cell volume, but other studies have suggested the role of
ROS in cell volume regulation [163]. There is a large increase in ROS production when
the cells are exposed to hypoosmotic conditions, but this increase in ROS production
does not cause cell injury.
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